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English summary 
Background and aims: The importance of vitamin D in bone health is recognised and low 
concentrations have been associated with increased risk of disease. Cutaneous synthesis is 
considered the major source of vitamin D, but during winter where sufficient sun exposure is 
restricted at Northern latitudes, intake from food and dietary supplements become essential. 
Vitamin D intakes are lower than dietary recommendations in most populations and low vitamin D 
status is common.  
The PhD thesis is based on the VitmaD study in which a realistic and model derived fortification 
strategy was investigated in a real-life setting. The aim was to investigate the effect of increasing 
vitamin D intake by fortification of milk and bread to the amount recommended in the Nordic 
Nutrition recommendations (NNR) on serum 25(OH)D concentration in families during winter in 
Denmark (paper 1). Secondly, the aim was to assess vitamin D status and its determinants at 
baseline of the study (paper 2). Further, to model the relationship between total vitamin D intake 
and serum 25(OH)D taking into account potential effect modifiers and estimate required vitamin D 
intake during winter (paper 3). 
Methods: The VitmaD study was a randomized controlled trial in 782 children and adults (4-60 
years) recruited as 201 families. Families were randomly assigned to vitamin D fortified or 
nonfortified milk and bread for 6 months starting from September. The milk and bread replaced the 
subjects´ usual consumptions of products. Information on dietary intake, supplement use, health and 
lifestyle was obtained by self-administered web-based questionnaires. Serum 25(OH)D was 
analysed by liquid chromatography-tandem mass spectrometry (LC/MS-MS). Mixed models with 
family as a random factor were applied in all the statistical analyses. 
Results: At baseline of the study (late summer) the geometric mean (IQR) serum 25(OH)D 
concentration was 72.1 (61.5-86.7) nmol/L with no overall differences between age (P=0.190), 
gender (P=0.332) or age and gender groups (P=0.223) (paper 2). The prevalence of serum 
25(OH)D <50 nmol/L was 9 %. In the multiple analysis of all subjects, vitamin D status was 
negatively associated with BMI (P<0.001) and positively associated with dietary vitamin D 
(P=0.008), multivitamin use (P=0.019), solarium use (P=0.006), outdoor stay in light clothes 
(P=0.001), sun preference (P=0.002) and sun vacation (P<0.001). The intra-family correlation was 
  
stronger in children (0.42) compared with adults (0.24). Thus children within a family seemed to be 
more alike than adults within a family with respect to vitamin D status. 
The planned fortification strategy was to increase the vitamin D intake to 7.5 µg/day. This 
succeeded in 66 % of the subjects in the fortification group with a median vitamin D intake 
(habitual diet plus fortified milk and bread) of 9.4 µg/day compared with 2.2 µg/day in the control 
group (paper 1). During winter the serum 25(OH)D concentration decreased from 73.1 to 67.6 
nmol/L (-∆5.5 nmol/L) in the fortification group (P<0.001) and from 71.1 to 41.7 nmol/L (-∆29.4 
nmol/L) in the control group (P<0.001). The final serum 25(OH)D concentration was significantly 
higher in the fortification group compared with in the control group (P<0.001, interpreted estimate 
1.59) and the treatment effect was not affected by BMI, multivitamin use and sun vacation. The 
prevalence of serum 25(OH)D <50 nmol/L remained low in the fortification group (16 %) whereas 
it increased to 65 % in the control group. 
The relationship between total vitamin D intake from natural foods, fortified milk and bread and 
dietary supplements and serum 25(OH)D concentration in winter was best fitted by a non-linear 
curve (paper 3). The effect of total vitamin D intake on serum 25(OH)D concentration was 4 % 
higher in men compared with women (P<0.014) and 10 % higher in the group with lowest initial 
25(OH)D concentration (<61.5 nmol/L) compared with the group with highest initial 25(OH)D 
concentration (>86.9 nmol/L) (P<0.001). It was not modified by age (P=0.132) or BMI (P=0.884). 
Estimated required vitamin D intake was 5, 11, 23 and 39 µg/day for 50, 75, 90 and 95 % of the 
population to maintain vitamin D status >50 nmol/L during winter. These figures were higher for 
the group with lowest initial 25(OH)D concentration (11, 18, 34 and >34 µg/day) and lower for the 
group with highest initial 25(OH)D concentration (<1, 3, 8 and 17 µg/day). 
Conclusions: In the population of Danish families, serum 25(OH)D concentration was above 50 
nmol/L in late summer and it was associated with both dietary and sun related factors. Children 
within a family seemed to be more alike than adults within a family with respect to vitamin D 
status. Vitamin D fortification of milk and bread reduced the decrease in serum 25(OH)D 
concentration during winter and ensured concentrations above 50 nmol/L. The relationship between 
total vitamin D intake and vitamin D status was non-linear. Estimated total vitamin D intake to 
maintain serum 25(OH)D above 50 nmol/L was largely dependent on the initial vitamin D status. 
 
  
Dansk resumé 
Baggrund og formål: Betydningen af D-vitamin for knoglesundhed er anerkendt og lave 
koncentrationer er forbundet med øget risiko for visse sygdomme. Syntese af D-vitamin i huden 
betragtes som den primære kilde til D-vitamin, men om vinteren på nordlige breddegrader, hvor 
solen ikke er tilstrækkelig til at danne D-vitamin, bliver indtag fra fødevarer og kosttilskud 
essentielt. D-vitaminindtaget er lavere end næringsstofanbefalinger i de fleste befolkninger og lav 
D-vitaminstatus er almindeligt. 
Ph.d.-afhandlingen er baseret på VitmaD studiet, hvor en realistisk og model baseret 
berigelsesstrategi blev undersøgt i et real-life setting. Formålet var at undersøge effekten af at øge 
D-vitaminindtaget ved berigelse af mælk og brød til det anbefalede indtag i de nordiske 
næringsstofanbefalinger (NNR) på serum 25(OH)D koncentrationen hos familier om vinteren i 
Danmark (artikel 1). For det andet var formålet at vurdere D-vitaminstatus og dens determinanter 
ved baseline af studiet (artikel 2). Endvidere var formålet at modellere forholdet mellem det totale 
D-vitaminindtag og serum 25(OH)D under hensyn til eventuelle effektmodifikatorer og at estimere 
krævet D-vitaminindtag om vinteren (artikel 3). 
Metoder: VitmaD studiet var et randomiseret kontrolleret forsøg i 782 børn og voksne (4-60 år) 
rekrutteret som 201 familier. Familierne blev randomiseret til D-vitaminberiget eller ikke-beriget 
mælk og brød i 6 måneder startende fra september. Det udleverede mælk og brød erstattede 
deltagernes sædvanlige forbrug af produkterne. Information om deltagernes kostindtag, 
kosttilskudsbrug, sundhed og livsstil blev indsamlet med selvadministrerede webbaserede 
spørgeskemaer. Serum 25(OH)D blev analyseret ved væskechromatografi tandem masse 
spektrometri (LC/MS-MS). Mixede modeller med familie som en tilfældig faktor blev anvendt i alle 
de statistiske analyser. 
Resultater: Ved baseline af studiet (sensommer) var den geometriske middel (IQR) serum 
25(OH)D koncentration 72,1 (61,5-86,7) nmol/L med ingen overordnede forskelle mellem alder 
(P=0,190), køn (P=0,332) eller alder- og kønsgrupper (P=0,223) (artikel 2). Prævalensen af serum 
25(OH)D <50 nmol/L var 9 %. I den multiple analyse af alle deltagerne var D-vitaminstatus 
negativt associeret med BMI (P<0,001) og positivt associeret med D-vitaminindtag fra kosten 
(P=0,008), multivitaminbrug (P=0,019), solariumbrug (P= 0,006), udendørsophold i let påklædning 
(P=0,001), solpræference (P=0,002) og solferie (P<0,001). Intra-familie korrelationen var stærkere 
  
hos børn (0,42) sammenlignet med voksne (0,24). Således var børn indenfor en familie 
tilsyneladende mere ens end voksne indenfor en familie i forhold til D-vitaminstatus. 
Den planlagte berigelsesstrategi var at øge D-vitaminindtaget til 7,5 µg/dag. Dette lykkedes i 66 % 
af deltagerne i berigelsesgruppen med et mediant D-vitaminindtag (sædvanlige kost plus beriget 
mælk og brød) på 9,4 µg/dag sammenlignet med 2,2 µg/dag i kontrolgruppen (artikel 1). Henover 
vinteren faldt serum 25(OH)D koncentrationen fra 73,1 til 67,6 nmol/L (- Δ5.5 nmol/L) i 
berigelsesgruppen (P<0,001) og fra 71,1 til 41,7 nmol/L (-Δ29.4 nmol/L) i kontrolgruppen 
(P<0,001). Den endelige serum 25(OH)D koncentration var signifikant højere i berigelsesgruppen 
sammenlignet med i kontrolgruppen (P<0,001, fortolket estimat 1,59), og berigelseseffekten blev 
ikke påvirket af BMI, multivitaminbrug og solferie. Prævalensen af serum 25(OH)D <50 nmol/L 
forblev lav i berigelsesgruppen (16 %), mens den steg til 65 % i kontrolgruppen. 
Sammenhængen mellem det totale D-vitaminindtag fra naturlige fødevarer, beriget mælk og brød 
og kosttilskud og serum 25(OH)D koncentration om vinteren var bedst modelleret med en ikke-
lineær kurve (artikel 3). Effekten af det totale D-vitaminindtag på serum 25(OH)D koncentrationen 
var 4 % højere hos mænd sammenlignet med kvinder (P<0,014) og 10 % højere i gruppen med 
lavest initial 25(OH)D koncentration (<61,5 nmol/L) sammenlignet med gruppen med højest initial 
25(OH)D koncentration (>86,9 nmol/L) (P<0,001). Effekten var ikke modificeret af alder 
(P=0,132) eller BMI (P=0,884). Det estimerede D-vitaminindtag var 5, 11, 23 og 39 µg/dag for at 
opretholde D-vitaminstatus >50 nmol/L i 50, 75, 90 og 95 % af populationen henover vinteren. 
Disse indtag var højere for gruppen med lavest initial 25(OH)D koncentration (11, 18, 34 og >34 
µg/dag) og lavere for gruppen med højest initial 25(OH)D koncentration (<1, 3, 8 og 17 µg/dag). 
Konklusioner: I populationen af danske familier var serum 25(OH)D koncentrationen over 50 
nmol / L i sensommeren og den var associeret til både kost-og solrelaterede faktorer. Børn indenfor 
en familie syntes at være mere ens end voksne indenfor en familie med hensyn til D-vitaminstatus. 
D-vitaminberigelse af mælk og brød reducerede faldet i serum 25(OH)D koncentrationen henover 
vinteren og sikrede koncentrationer over 50 nmol/L. Sammenhængen mellem det totale D-
vitaminindtag og D-vitaminstatus var ikke-lineær. Estimeret totalt D-vitaminindtag for at 
opretholde serum 25(OH)D over 50 nmol/L var afhængig af den initiale D-vitaminstatus. 
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1 Rationale and aims of the study 
Vitamin D is a hormone like vitamin that is provided by both intakes and endogen synthesis after 
skin exposure to sun light. Cutaneous synthesis is considered the major source of vitamin D, but 
during winter where sufficient sun exposure is restricted at Northern latitudes, intake from food and 
dietary supplements become essential. It is still discussed which vitamin D status is optimal for 
health and how to reach this target. Vitamin D intake in Denmark and other populations is lower 
than the recommendation and low vitamin D status is common. As relatively few foods contain 
vitamin D naturally and sun exposure should be limited due to risk of skin cancer, it is hard to meet 
the vitamin D requirement by a normal, healthy lifestyle. Therefore it is relevant to investigate 
methods to increase the vitamin D intake and there are different ways to consider 
(1)
 : advice on sun 
exposure, dietary diversification e.g. increase fish intake, dietary supplements and food fortification. 
It may not be ethical to recommend an increased sun exposure due to the risk of skin cancer. 
Dietary diversification or supplementation may not be fully implemented in a population and may 
be dependent on social and financial status 
(2, 3).
 Furthermore, public advice is mostly followed by 
the health conscious and paradoxically dietary supplements are often taken by those that have the 
least need for it 
(4).
 Food fortification is a strategy that targets the entire population 
(1) 
at least if it is 
implemented on a mandatory basis. The focus of the present research was a targeted vitamin D 
fortification strategy based on models on usual food consumption in the Danish population and the 
effects of implementing it in a real-life setting. The outcome of the research is the three attached 
papers with the following aims: 
Paper 1: To investigate the effects of increasing vitamin D intake by fortification of milk and bread 
to the amount recommended in the Nordic Nutrition Recommendation (NNR) on serum 25(OH)D 
concentration in families during a 6-mo winter period in Denmark. 
Paper 2: To assess serum 25(OH)D concentration and its determinants in children and adults 
among families in late summer in Denmark. 
Paper 3: To investigate the relationship between total vitamin D intake from natural foods, fortified 
foods and dietary supplements and vitamin D status in children and adults in late winter in Denmark 
taking into account the initial vitamin D status, age, gender and BMI class. Furthermore, we 
estimated the vitamin D intake needed to maintain 25(OH)D concentration >25 and >50 nmol/L in 
specified proportions of the population. 
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2 Background 
2.1 Vitamin D 
2.1.1 Metabolism and function 
Vitamin D is provided by both endogen synthesis and as a nutrient through food or supplements and 
it exists in two native forms ergocalciferol (vitamin D2) and cholecalciferol (vitamin D3). In the 
following vitamin D refers to both forms unless otherwise stated as they are metabolized in an 
identical manner (Figure 1). Vitamin D is synthesized when the skin is exposed to ultraviolet B 
(UVB) light in the wavelengths 290-315 nm 
(5)
. In the epidermis 7-dehydrocholesterol is converted 
to previtamin D3 that is rapidly converted to vitamin D3 in a heat dependent process 
(6)
. This 
synthesis is dependent on the amount of solar UVB photons reaching the surface of the earth which 
is influenced by the ozone layer, smog and the zenith angle of the sun and thus on latitude, season 
and time of the day 
(5-9)
. This is why when the zenith angle is increased during wintertime and in the 
early morning and late afternoon, little if any vitamin D is synthesized in the skin at latitudes above 
40 °N 
(5, 8, 9)
. Aging and skin pigmentation also reduce the skin´s capacity to produce vitamin D as 
well as blocking of the skin with clothing and proper applied sunscreen reduces the synthesis of 
vitamin D 
(5, 10, 11)
. After synthesis vitamin D3 diffuses into the circulation and is transported to the 
liver bound to vitamin D binding protein (DBP). Consumed vitamin D, either as vitamin D2 or 
vitamin D3, is absorbed in the intestine and transported via chylomicrons and the lymphatic system 
to the liver. From here vitamin D from both sources undergoes two hydroxylation steps in order to 
become active 
(12)
. 
In the liver vitamin D is hydroxylated to 25-hydroxyvitamin D (25(OH)D, calcidiol) by the enzyme 
vitamin D-25-hydroxylase. This conversion seems to be only loosely regulated and to depend 
primarily on the concentration of vitamin D 
(13)
. Bound to DBP 25(OH)D is the major circulating 
form of vitamin D with a relatively long half-life of 2-3 weeks 
(14) 
and its concentration is used as a 
biomarker of vitamin D status 
(15)
. 25(OH)D is further hydroxylated to its biologically active form 
1,25-dihydroxyvitamin D (1,25(OH)2D) by the 1α-hydroxylase enzyme primarily in the kidney 
(15-
17). Several extrarenal tissues also express 1α-hydroxylase (18, 19), and the 1,25(OH)2D produced here 
acts locally in an autocrine or paracrine fashion to regulate the cell´s  own proliferation and 
differentiation and generally does not reach the circulation 
(14)
. In contrast to 25(OH)D, circulating 
1,25(OH)2D has a short half-life of around 4-6 hours and its concentration is tightly homeostatic 
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regulated by calcium and phosphate concentrations via a negative feedback mechanism with 
parathyroid hormone (PTH) 
(16, 20)
. From the kidney 1,25(OH)2D enters the circulation and travels 
bound to DBP to its target tissues, where it mediates its action by binding to the vitamin D receptor 
(VDR) 
(19, 21, 22)
. The major target tissues are the intestine and bone 
(15)
, but several other tissues 
have VDR activity 
(21, 22)
. Biological responses are generated both by regulating gene transcription 
(genomic response) and by rapidly activating a variety of signal transduction pathways at or near 
the plasma membrane (rapid response) 
(14)
. Vitamin D can be stored in fat and other tissues 
(23) 
and 
although it is presently unknown, these stores may not be readily available when needed 
(24)
. If not 
stored vitamin D is excreted from the body via the bile in the form of water-soluble, inactive 
metabolites 
(25)
. 
The principal function of vitamin D is to maintain blood concentrations of calcium and phosphorus 
within the normal range 
(13)
 (Figure 1). Calcium is essential for development and maintenance of 
bone and numerous cellular functions including muscle contraction and nerve conduction 
(26)
. 
Calcium sensing receptors are present in the parathyroid gland, and low blood calcium 
concentrations induce the release of PTH that in return rapidly stimulates the production of 
1,25(OH)2D which increases the serum calcium (and phosphorus) concentration through three 
separate activities 
(12)
: directly enhances intestinal absorption and interacts with PTH to stimulate 
renal reabsorption and mobilization from bone. In this endocrine system dietary calcium is favoured 
over mobilization from bone to support serum concentrations under normal conditions 
(12)
. It has 
also been suggested that bone cells can convert 25(OH)D to 1,25(OH)2D to have a direct anabolic 
function on bone when calcium supply is adequate 
(27, 28)
. Higher serum calcium concentrations 
suppress the PTH secretion and induces 24-hydroxylase in the kidney to convert 25(OH)D and 
1,25(OH)2D to 24,25-dihydroxyvitamin D 
(25, 29)
. Although this metabolite may also have a 
biological function 
(15)
, it is less potent than 1,25(OH)2D and it is generally considered as the first 
step to inactivate and degrade 25(OH)D 
(15)
. In addition to this negative feedback mechanisms with 
PTH, 1,25(OH)2D also down-regulates its own production by inducing the 24-hydroxylase 
(14)
. 
As 1α-hydroxylase and VDR are expressed in numerous cell types (30) additional non-classic 
functions of vitamin D have been suggested. These include regulation of cell differentiation and 
proliferation, cellular growth and hormone secretion 
(31)
. For example vitamin D may play a role in 
the immune system, growth of cancer cells and blood pressure regulation 
(32)
.
 
 5 
 
 
 
Figure 1. Vitamin D metabolism, regulation and primary functions. BMD, bone mineral density; DBP, vitamin D 
binding protein; 7-DHC, 7-dehydrocholesterol; PTH, parathyroid hormone; UVB, ultraviolet B; VDR, vitamin D 
receptor. 
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2.1.2 Deficiency and toxicity 
Low vitamin D concentrations will often be accompanied by elevated PTH concentrations known as 
secondary hyperparathyroidism with normal to high bone turnover 
(32, 33)
. The classic disease of 
vitamin D deficiency is rickets in children and osteomalacia in adults caused by an impaired 
mineralization of bone 
(32, 34)
. Rachitis is characterized by growth retardation, pain, soft bone and 
skeletal deformities and in some children also muscle weakness 
(32, 35)
. The symptoms in adults are 
less pronounced and may be diffuse pain in bone and muscles. Prolonged and less severe vitamin D 
deficiency may lead to weak bone and contribute to development of the longer latency disease 
osteoporosis by reducing calcium absorption 
(13, 29, 36)
. Osteoporosis is characterized by low bone 
mass and structural deterioration of bone tissue that increases bone fragility and the risk of fractures 
(29)
. As these symptoms are irreversible, a high peak bone mass early in life is prudent 
(36) 
and thus 
sufficient vitamin D is essential throughout the life cycle even though symptoms of severe 
deficiency are not present. Rickets and osteomalacia occur seldomly in Denmark and mostly among 
immigrants 
(37, 38)
, but osteoporosis has substantial public health implications 
(29, 39)
. The estimated 
prevalence of osteoporosis in persons aged 50 years or more in Denmark is 41 % among women 
and 18 % among men 
(40). Low vitamin D concentrations have also been associated with a range of 
health outcomes 
(25, 41) 
including an increased risk of cardiometabolic disease 
(42)
, certain types of 
cancer 
(43)
, autoimmune diseases 
(44) 
and mortality 
(45)
. 
As vitamin D can be stored in the body it is potential toxic. However, vitamin D intoxication is rare 
and most likely to occur from very high intakes of dietary supplements as endogenously synthesized 
vitamin D is limited by photodegradation in the skin after prolonged UVB exposure 
(5, 13)
. Acute 
toxic effects of vitamin D are hypercalcemia and hyperphosphatemia and chronic toxicity can lead 
to internal organ calcification and failure 
(46)
. Vitamin D intoxication is usually not seen with serum 
25(OH)D concentrations <375 nmol/L and daily intakes <250 µg/day 
(47, 48)
. However, serum 
25(OH)D concentrations lower than what causes acute toxicity may potentially have adverse health 
effects 
(46)
, and the consequences of prolonged higher vitamin D intakes (>25 µg/day) on health are 
not known 
(49)
. Due to the findings of U-shaped or reverse-J-shaped associations between 25(OH)D 
concentration and  some health outcomes for example mortality, the US dietary committee 
suggested that potential adverse effects may occur at concentrations >125 nmol/L 
(47)
. The U-
shaped associations have been critiqued for being due to statistical interference 
(50)
. The Tolerable 
Upper Intake Level (UL) defines the maximum level of total chronic daily intake of a nutrient 
 7 
 
judged to be unlikely to pose a risk of adverse health effects to humans 
(51)
. The new UL for vitamin 
D was set at 100 µg/day for adults and children aged 11-17 years and at 50 µg/day for children aged 
1-10 years based on hypercalcaemia and impaired growth in children 
(52)
. 
 
2.1.3 Measurement of status 
Circulating concentration of 25(OH)D is generally accepted as the best marker of vitamin D status 
as it reflects the sum of vitamin D from intakes and cutaneous synthesis 
(53)
. Several methods for 
quantification of 25(OH)D have been developed over the years. These have moved from 
competitive protein binding assays that could not be automated, to automated immunoassay (radio, 
enzyme-linked or chemiluminescence based) and liquid chromatography techniques (HPLC or LC-
MS/MS) 
(54, 55)
. In the present research we used the LC-MS method that might be considered the 
golden standard 
(55-57)
. Immunoassays are the most common method due to their ease of use, relative 
cost and high sample throughput, but they are limited in their ability to detect vitamin D2 
(55)
. The 
chromatographic methods are more specific and allow determination of several vitamin D 
metabolites 
(58, 59)
. However, they are also more expensive and labour-extensive and the use of 
different in-house procedures has been criticized 
(55)
. Therefore a LC-MS candidate reference 
method has been developed by the National Institute of Standards and Technology (NIST) 
(60)
. 
Partly due to lack of standardization, several studies have shown that different assays as well as 
laboratories can yield markedly differing results 
(57, 61-67)
. In 2010, an International standard 
reference material was introduced by NIST 
(68) 
which may improve method-related variability. This 
calibrator has been used for analysis of serum 25(OH)D in the present research. The Vitamin D 
External Quality Assessment Scheme (DEQAS) supports the evaluation of different assays and 
individual laboratory performances 
(69)
. In DEQAS the LC-MS method is positively biased for the 
All-Laboratory Trimmed Mean (ALTM) whereas the immunoassays are mostly negatively biased 
(62)
. Furthermore, standardization of results from National surveys is on-going in the VDSP with the 
purpose to be able to compare results with liability 
(70, 71)
. 
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2.1.4 Status and cut-off limits 
Low vitamin D status with seasonal variations has been found in various groups in the Danish 
(72-77) 
and other populations 
(75, 78-87)
. Several factors such as age, BMI, sun habits, ethnicity, dietary intake 
and supplement use have been associated with vitamin D status so that pigmented skin, limited 
sunlight exposure, obesity and increasing age are risk factors for vitamin D deficiency 
(88)
. There is 
no International standard for definition of deficient and optimal vitamin D concentrations and cut-
off values are still discussed. The traditional approach was to determine vitamin D sufficiency as 
the point where clinical symptoms of rickets and osteomalacia were avoided 
(29)
. It is recognized 
that a 25(OH)D concentration <12.5 nmol/L can result in rickets and osteomalacia and that 
concentrations <20-25 nmol/L may also result in these diseases 
(32, 35, 89)
. However, prevention of 
clinical symptoms is not the same as optimal 25(OH)D concentration since less severe degrees of 
deficiency may produce longer-latency diseases such as osteoporosis 
(29, 90)
. Current research 
focuses on defining optimal vitamin D concentrations for health outcomes rather than the lack of 
explicit clinical disease 
(91)
. 
To better understand the adequacy of vitamin D supply for biological responses, serum 25(OH)D 
concentrations have been associated with functional markers such as PTH,  calcium absorption, 
bone mineral density (BMD), bone resorption and fracture rates 
(53, 90-95)
. PTH has received the most 
attention to date. An inverse relation between 25(OH)D and PTH concentration has been found in 
numerous studies with maximal PTH suppression around 75-100 nmol/L 
(13, 33, 96-100)
. However, a 
large cross-sectional study among 20-60 year olds did not find a threshold for PTH suppression and 
that the relation was strongly age-dependent so that PTH concentrations were elevated at higher age 
for the same concentration of 25(OH)D 
(101)
. Most of the research focused on adults, and in children 
there was not enough evidence to support the use of BMD and PTH as functional markers 
(102)
. 
Despite the limited evidence for the use of functional markers in children, it has mostly been 
assumed that children have the same requirements as adults. 
In Denmark, the following values have commonly been used to define deficient, insufficient and 
sufficient vitamin D status: <25, 25-50, >50 nmol/L 
(103)
. These are the limits that were used in the 
present research for discussion except in paper 1 where the American limit for deficiency was used. 
In the US dietary reference intake for vitamin D, 30 nmol/L was set as the limit beyond which 
adverse effects on bone might increase and 50 nmol/L was used as the sufficient level to maintain 
bone in 97.5 % of the population. Some argue that 25(OH)D concentrations in the interval 75-125 
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nmol/L should provide the benefit of vitamin D while limiting the risk of potential harm  
(95, 98, 104-
106)
. 
 
2.1.5 Dietary intake 
The general population derives most of its vitamin D from endogen synthesis after sun exposure 
(24)
. 
However, when sufficient sun exposure is restricted, for example during winter at higher latitudes 
(5, 
9)
, dietary vitamin D becomes essential 
(107, 108)
. Furthermore, due to limited sun exposure as a 
consequence of changes in life style such as being more inside and increased awareness about skin 
cancer 
(30)
, dietary intakes may play a larger role than previously assumed 
(109)
. Vitamin D in the 
diet is mainly provided in the form of vitamin D3 which is found in animal sources such as fish, 
meat, milk and eggs 
(10, 110)
. Vitamin D2 is found in certain plants and in mushrooms exposed to 
UVB light 
(111-113)
. Both vitamin D2 and D3 are used in dietary supplements, however, in Denmark it 
is mostly in the form of vitamin D3. It appears that vitamin D2 and D3 possess equal bioavailability, 
but vitamin D3 may be more potent to sustain the 25(OH)D response 
(114-119)
. However, this is 
controversial 
(120, 121) 
and the meaning of the prompting of a higher clearance by vitamin D2 on the 
function of vitamin D is unclear 
(115)
. 25(OH)D may also be present in foods and it is around five 
times more potent than vitamin D3 to raise serum 25(OH)D 
(122, 123)
. Although there is uncertainty 
about this conversion factor 
(110, 124)
, it has been suggested that the impact of 25(OH)D in foods is 
highly underestimated 
(109)
. 
 
Figure 2. Relative contributions of food groups to the vitamin D intake in Denmark 
(129)
. 
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Relatively few foods contain vitamin D naturally and concentrations may vary depending on among 
other things the breeding circumstances and the feed 
(125)
. For example the vitamin D content in 
wild caught salmon has been found to be four times higher compared to farmed salmon 
(10) 
and to 
range from 2.5 to 25 µg/100 g in various species 
(10)
. Fish is the major contributor to the vitamin D 
intake in Denmark (Figure 2). In other countries where food fortification is more widespread than 
in Denmark for example in Ireland, the UK, Spain, USA and Canada fortified foods are a 
significant contributor as well 
(126, 127)
. Milk is mandatorily fortified with vitamin D in Canada and 
provides almost half of the vitamin D intake and contributes even more than fish to the total intake 
(128)
. 
The mean vitamin D intakes from foods in Denmark are 2.3 and 3.4 µg/day (median 1.8 and 2.5 
µg/day) for children aged 4-17 years and adults aged 18-75 years 
(129)
. These intakes are lower than 
the recommended intake (RI) by the Nordic Nutrition Recommendation (NNR) that was recently 
increased from 7.5 to 10 µg/day 
(130, 131)
. However, dietary supplement use is common in Denmark, 
and the median total vitamin D intake in supplement users was 7.6-8.4 µg/day 
(132)
. The US dietary 
guidelines set the Recommended Daily Allowance (RDA) (corresponding to the RI) for vitamin D 
to 15 µg/day 
(47)
. Vitamin D recommendations in Europe range from 2.5 to 10 µg/day 
(133)
. 
Generally, vitamin D intakes are low and lower than the dietary recommendations in most 
populations 
(3, 86, 87, 134-137)
. 
 
2.2 Dietary assessment methods 
Different dietary assessment methods exist including the food frequency questionnaire (FFQ), 
dietary record (eventually weighed) and dietary recalls either 24-hour or history 
(138, 139)
. They all 
have their strengths and limitations and choice of method should be based on the food group or 
nutrient of interest and the target group. In the present study we used the FFQ which retrospectively 
report the frequency of consumption of selected food items and it is designed to estimate usual 
intake over a specified period of time 
(138)
. Dietary history is a long-term method similar to FFQ, but 
it provides more details. 24-hour recall is a detailed registration of all foods and beverages 
consumed the last day. Dietary record is the only prospective method and it uses a detailed protocol 
of all foods and beverages consumed over typically 3-7 days with weighed or estimated portion 
sizes. The short-term methods (dietary record and 24-hour recall) allow greater specificity for 
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describing foods and food preparation methods than FFQ, and the dietary record has the advantage 
of not relying on the memory of the respondent, but they also have a high respondent burden, are 
unrepresentative of usual intake if only a few days are assessed and they are generally expensive as 
they require a large effort to collect and process data 
(138)
. Recording the diet may also influence the 
usual dietary pattern of the respondent which is not the case with the retrospective methods 
(138, 139)
. 
The dietary record is self-administered whereas the 24-hour recall requires highly trained 
interviewers. These methods are often used to validate FFQ which is the most commonly used 
method for measuring dietary exposures in epidemiologic studies 
(138, 140)
. For vitamin D the dietary 
record is the most frequently used reference method for validating FFQ 
(140)
. The FFQ is simpler 
than other methods and has the advantage of easier administration, low cost and burden on 
respondents, but may be limited through poor design and inappropriate use 
(141)
. The limitations of 
the FFQ are the reliance on memory, the ability of the subjects to accurately report and the use of 
estimated portion sizes. When designing a FFQ, it is important to consider the length of the 
reference period, frequency categories, number of food items, how portion sizes are described (self-
defined versus fixed and eventually use of pictures), format (food list versus meal based) and 
administration (interviewer-based versus self-administered, paper and pen versus computerized). 
The highest correlations in validation studies were seen when respondents were able to describe 
their own portion sizes, with the highest number of food items and when the administration was 
interviewer-based 
(141)
. 
An advance in dietary assessment is the increasing use of digital technologies such as computers, 
the internet, cameras and mobile phones 
(142, 143) 
as was also applied in the present study. It is must 
faster and cheaper to collect and process data in this way. Its limitations is that respondents with no 
access to the digital instrument used will not be included if the method is self-administered. The 
interviewer based approach can still be computerized to optimize data collection time. Furthermore, 
web-based methods have given higher compliance due to the flexibility of completion at any time 
and location, personalized feedback and interactive help, it required less time and the respondents 
felt less observed and more independent and it enables communication with dispersed populations 
(142)
. This requires of course a high internet access in the population of interest. 
As the main dietary source of vitamin D is fish, which may not be consumed frequently or on a 
regular, daily basis, it is important to assess the intake of a longer period of time. Even a 7-day 
dietary record may not capture an eventual fish intake, and it would be too demanding for the 
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subjects to complete a dietary record >7 days. Generally, it is said that the intake over 
approximately one month would be necessary to estimate a subjects´ usual fish intake. Thus, FFQ 
seemed to be the best choice to estimate vitamin D intake in the present study. Validation studies on 
FFQs designed to assess vitamin D intake generally showed acceptable correlations between FFQ 
and other methods, though FFQs tend to overestimate the vitamin D intake compared with the 
dietary record 
(144-148)
. 
 
2.3 Fortification  
Food fortification is not widely used in Denmark due to a previously restrictive regulation viewing 
fortification as unnecessary and a conservative attitude in the population 
(127)
. It was only allowed to 
fortify a food product if it could be justified that there was a nutritional need in the population. In 
2006 the regulation on addition of vitamins and minerals to foods was harmonised within the 
European Union in order to facilitate the free movement of foods 
(149)
. If a company wants to market 
a fortified food product they need an approval from the Danish Veterinary and Food 
Administration. They consider if the product possesses a risk for any groups in the population and if 
not an approval is given. This authority can also give general authorizations to fortify a group of 
foods with a vitamin in a given amount or they can state mandatory fortification practices. 
Foods can be fortified by different methods either directly added to a food product for example milk 
or indirectly during processing for example added to the flour for baking of bread and cakes. 
Another method is bio-fortification where the natural content of the vitamin in the food is enhanced 
for example during the feed to cows and thus the resulting milk or meat can have an increased 
concentration of vitamin D. Another example of bio-fortification is mushrooms exposed to UVB 
light 
(111-113)
. When the present study was initiated in 2010 some margarine were fortified with 
vitamin D in Denmark. Just after the data collection was finished in spring 2011 the first vitamin D 
fortified milk was introduced. In the following period another vitamin D fortified milk, a rye bread 
and a mineral water became available in the stores. Generally, the consumption of fortified foods in 
Europe has increased over the years 
(127)
. It is mostly margarines that are voluntarily fortified with 
vitamin D and/or milk and in some cases also breakfast cereals 
(91, 150, 151)
. In Island, Sweden and 
Finland some milks and margarines are vitamin D fortified. Since 2003 almost all margarines and 
milk in Finland except for the organic milk have been fortified with vitamin D (0.5 µg D3/100 mL 
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milk and 10 µg D3/100 g margarine) on the recommendation from the authorities. Therefore this 
country is a case for evaluating the impact of a national vitamin D optimisation policy. The 
initiative improved vitamin D intake and status in some groups 
(152-154) 
whereas it had minor effects 
in other groups 
(155)
. In USA almost all milk is fortified with vitamin D, as are many ready-to-eat 
cereals, some yogurt, margarines and orange juices 
(156)
. Other dairy products made from milk, such 
as cheese and ice cream, are generally not fortified. In Canada milk and margarines are mandatorily 
fortified with vitamin D. Despite widespread vitamin D fortification in USA and Canada and that 
fortified foods constitute a large part of the dietary vitamin D, the vitamin D intake is still lower 
than the RDA in most groups 
(126, 128, 156, 157)
. Although food fortification has improved vitamin D 
status in some groups 
(127)
, current practices do not seem to be optimal for improving vitamin D 
status in the general population. It might be due to the skewness of milk intake across population 
groups 
(155, 156)
. 
It illustrates the importance of targeting the fortification strategy and finding the right foods to 
fortify and the appropriate levels. It has been suggested to fortify more food vehicles in lower 
concentrations to reach broader in the population 
(158)
. Previous fortification studies showed that the 
efficiency of vitamin D in fortified foods to increase serum 25(OH)D concentration is good (Table 
1) and equal to that of dietary supplements 
(159-162)
. Most of the studies used milk as the fortification 
vehicle and none of the studies used a combination of foods. Some used doses higher than what 
would be realistic in real-life and only few included children. 
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Table 1. Overview of studies investigating the effects of vitamin D fortified foods on serum 25(OH)D concentration. 
Type Location Population n Food Dose 
(µg/day) 
Duration Assay Change in 25(OH)D 
(control and 
fortification) 
Effect 
compared 
with control 
Reference 
RCT India Girls, boys 
10-14 y 
713 Milk 15, 25 12 wk CIA 29.4-27.1 
28.6-57.2 
29.9-69,2  ↑ ↑ 
(163)  
RT New 
Zealand 
Toddlers 
12-20 mo 
181 Milk ~3.7 20 wk RIA 48.8-52.6 
52.8-70.5 ↑ ↑ 
(164)  
RCT Ireland Women, 
men 
17-54 y 
102 Milk ~3.4 4-5 mo RIA 85-54 
77-62 
↓ ↑ 
(165)  
RCT New 
Zealand 
Women 
18-47 y 
73 Milk 
powder 
5 12 wk RIA 74-53 
76-65 ↓ ↑ 
(166)  
RCT UK Women, 
men 
 
40 Milk 
drinks 
5, 10 4 wk LC-
MS 
33.5-30.1 
31.3-43.2 
30.9-50.6 ↑ ↑ 
(167)  
RCT Mongolia Girls, boys 
9-11 y 
579 Milk 7.5 7 wk LC-
MS 
20-50 
25-72.5 ↑ ↑ 
(162)  
RCT China Women 
>55 y 
63 Milk 6.4 12 wk CIA 29.3-28.2 
33.1-39.5 ↑ ↑ 
(168)  
RCT Australia Men 
50-87 y 
167 Milk 20 2 y RIA 76.1-56.2 
77.2-84.6 ↑ ↑ 
(169)  
Cross-
sectional 
New 
Zealand 
Girls, boys 
mean 7.4 y 
89 School 
milk 
1.5 - RIA ->43.8 
->49.6 - ↑ 
(170)  
RCT Iran Diabetics 
30-60 y 
90 Youghurt 
drink 
25 12 wk HPLC 41.6-37.2 
44.4-77.7 ↑ ↑ 
(171)  
RCT Iran Diabetics 
30-60 y 
100 Youghurt 
drink 
12.5 12 wk HPLC 38.0-33.4 
38.5-72.0 ↑ ↑ 
(172)  
RCT Greece Women 
55-65 y 
101 Dairy 
products 
7.5 5 mo CIA 63.5-55.3 
69.8-63.5 no no 
(173)  
RCT Greece Women 
55-65 y 
66 Dairy 
products 
22.5 30 mo CIA 59.0-45.0 
53.8-63.0 ↑ ↑ 
(174)  
RCT Greece Women 
55-65 y 
173 Dairy 
products 
10 12 mo CIA 58.3-56.5 
57.0-61.0 ↑ ↑ 
(175)  
RCT Canada Women, 
men 
18-60 y 
80 Cheese 100 8 wk RIA 55-51 
55-110 
↑ ↑ 
(161)  
RCT France Women 
50-65 y 
71 Cheese 2.5 6 wk RIA 57.3-65.8 
58.8-67.8 no no 
(176)  
RCT USA Women, 
men 
18-84 y 
105 Orange 
juice 
25 11 wk LC-
MS 
49.5-45.3 
44.8-76.8 
↑ ↑ 
(159)  
RCT USA Women, 
men 
22-60 y 
26 Orange 
juice 
25 12 wk CPBA 50.0-73.0 
37.0-94.0 
↑ - 
(177)  
Single-
arm 
Romania Nursing-
home 
58-89 y 
45 Bread 125 12 mo RIA 28.5-125.6 
↑ - 
(178)  
RCT Finland Women 
25-45 y 
41 Bread 10 3 wk HPLC - 
↑ ↑ 
(160)  
CIA, chemiluminescence immunoassay; CPBA, competitive protein binding assay; HPLC, high-performance liquid chromatography; LC-MS, liquid 
chromatography mass spectrometry; RCT, randomized controlled trial; RIA, radioimmunoassay 
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3 Methods 
3.1 Study design 
My thesis and the three papers are based on the VitmaD study. The principle in the study design 
was to investigate a realistic fortification strategy in a real-life setting. VitmaD was a double-blind, 
randomized, placebo-controlled intervention trial with children and adults recruited as families. The 
families received either vitamin D3-fortified milk and bread or nonfortified placebo milk and bread 
for 6 months during the winter. Milk and bread were distributed to the families twice per week 
through three local supermarkets. A personal identification card informed each family which 
supermarket to go to and obtain products. The card ensured that families received the correct 
products and that products were handed out only to families who were participating in the study. 
Subjects were instructed to replace their usual consumption of milk and bread with the products 
provided in the study. In all other respects, subjects were requested to live their lives as normal 
without changing any habits. Adult subjects were seen three times during the study period (month 0, 
3 and 6), and children (4-17 years) were seen twice (month 0 and 6). Blood samples were drawn at 
all 3 visits, and anthropometric measures and blood pressure were recorded at month 0 and 6 
(Figure 3). The primary endpoint was serum 25(OH)D concentration, and secondary endpoints 
were plasma PTH and serum total calcium. Subjects were asked to complete questionnaires at 
months 0 and 6. The study protocol was approved by the Research Ethics Committee of the Capital 
Region of Denmark (record H-4-2010-020). 
 
 
Figure 3. Outline of the VitmaD study. 
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3.2 Subjects 
Sample size was calculated at 88 per group to detect a mean (±SD) difference in serum 25(OH)D 
concentration of 11 ± 26 nmol/L 
(165) 
between treatment groups at the 5 % significance level and 
with 80 % power. To be able to analyze female and male children and adults separately and allow 
for dropouts, we aimed to recruit 800 subjects who represented around 200 families. Subjects were 
recruited in Gladsaxe Municipality in Denmark (56 °N) drawn randomly from the Danish Civil 
Registration System. Families with a permanent address in Gladsaxe and 3-6 members in the 
household, including at least one child aged 4-17 years, were invited by letter to participate in the 
study. Inclusion criteria were age between 4 and 60 years and a permanent address in the Gladsaxe 
Municipality. Exclusion criteria were pregnancy and disease or use of a medication that would 
influence vitamin D metabolism (including dietary supplements with >10 µg vitamin D/day for 
children and >5 µg vitamin D/day for adults). There was an immense response to the letters, and 
registration was closed after 10 days. At that time, 429 families had responded to the invitation. 
After screening for eligibility, 230 families were selected, and invited to an information meeting. 
When the families hereafter decided on their participation, not all members of the household 
necessarily participated. All adult subjects and custody holders of children gave their written 
informed consent to participate, which resulted in a total of 782 subjects (201 families). One family 
withdrew before the study started, five families withdrew during the study, some of the children 
refused blood sampling, some of the subjects did only have one blood collection or insufficient 
blood to perform the analyses and not all of them had full questionnaire data (Figure 4). 
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Figure 4. Flow of subjects throughout the VitmaD study. 
  
Invited by letter 
(n = 4100 families) 
Responded before closing 
(n = 429 families) 
Invited to information meeting 
(n = 230 families) 
Excluded 
Not eligible (n = 131 families) 
Participant number already 
fulfilled (n = 68 families) 
Control group  
(n = 100 families) 
(n = 391 subjects) 
Did not want to provide the blood 
sample (n = 8 children) 
Did not find time for blood sampling 
(n = 1 family/3 subjects) 
 Travelling, tired of study bread 
(n = 2 families/6 subjects) 
 Lost contact 
(n = 2 families/8 subjects) 
Did not want to provide the last 
blood sample (n = 7 children) 
 Insufficient blood collection at month 
6 (n = 4 subjects) 
 No questionnaire data at month 6 
(n = 17 subjects) 
Did not want to provide the blood 
sample (n = 2 children)  
Private reasons 
(n = 1 family/3 subjects) 
 Travelling, unknown reason 
(n = 2 adults) 
 Did not want to provide the last 
blood sample (n = 9 children) 
 Insufficient blood collection at month 
6 (n = 4 subjects) 
 No questionnaire data at month 6 
(n = 19 subjects) 
Analyzed  
(Paper 1: n = 726 subjects) 
(paper 2: n = 755 subjects) 
(paper 3: n = 692 subjects) 
Did not show up or declined to 
participate (n = 29 families) 
Randomized 
(n = 201 families) 
Excluded from analysis 
Withdrew during study 
Withdrew before start 
Fortification group 
(n = 101 families) 
(n = 391 subjects) 
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3.3 Fortification model 
The fortification model was built on the following 3 criteria: the model should include a 
combination of foods, foods should be consumed regularly in the chosen age group and foods 
should be low in fat and sugar. On the basis of these criteria, milk and bread were chosen as foods 
to include in the model. 
The fortification strategy was to increase the vitamin D intake to 7.5 µg/day (the RI at that time 
(131)
) in as many subjects as possible while avoiding an intake above the UL (25 µg/day for children 
and 50 µg/day for adults at that time 
(51)
). The choice of fortification amounts was based on models 
generated from dietary intake data from the Danish National Survey of Dietary Habits and Physical 
Activity (7-day consecutive dietary record) 
(129)
. These models used the vitamin D intake from 
natural foods and the consumption of milk and bread fortified in varying amounts of vitamin D 
(Figure 5). We selected the model where the largest proportion of the population was within the 
interval 7.5-15 µg/day thus allowing for the use of multivitamin supplements with 10 µg vitamin D 
per day which would add up the total vitamin D intake to the UL of 25 µg/day. The most vulnerable 
groups for excess intake was evaluated to be boys aged 6-9 years and girls aged 4-5 years, and 
special attention was paid for these groups in the selection of fortification model. 
 
Figure 5. Cumulated vitamin D intake for different fortification models based on data from the Danish National Survey 
of Dietary Habits and Physical Activity 
(129)
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Study milks were organic homogenized 0.5 % fat milk produced by Arla Foods A/S. The fortified 
milk had a vitamin D3 (cholecalciferol; Kemikalia) concentration of 0.38 µg/100 mL, which was 
confirmed by analysis in triplicate during the study period (0.40±0.01 µg/100 mL). The placebo 
milk did not contain added vitamin D (<0.004 µg/100 mL). Study breads included white bread, 
brown bread, rye bread, and buns that were baked from wheat- and rye-flour blends produced by 
Lantmännen Cerealia A/S. Vitamin D3 (cholecalciferol; DSM Nutritional Products) was added to 
flour blends to bake fortified breads. Before and after the study period, samples from 3 different 
flour blends of both types were analyzed, and the added vitamin D was recovered. Twice during the 
study period, breads of each type were collected on 3 consecutive baking days and analyzed in 
pools of 4 breads. We aimed to produce fortified breads with 6 mg vitamin D3/100 g bread, but the 
analyses showed a concentration of 5.2±0.3 µg vitamin D3/100 g in the wheat bread and 4.3±0.3 µg 
vitamin D3/100 g in the rye bread. The placebo bread did not contain added vitamin D. 
Concentrations of vitamin D in study milks and breads were analyzed at the National Food Institute, 
Technical University of Denmark, by using a reverse-phase HPLC method described elsewhere 
(179)
. 
Analyses were accredited according to the standard ISO 17025 
(180)
. 
 
3.4 Questionnaires 
At baseline (month 0), subjects completed a detailed self-administered Web-based questionnaire 
that assessed their background, health, sun exposure and lifestyle including use of dietary 
supplements and a semi-quantitative FFQ that assessed their vitamin D and calcium intakes before 
the study. By the end of the study (month 6), questionnaires were repeated to assess eventual 
changes in health or lifestyle and vitamin D and calcium intakes during the study. The two FFQs 
were also used to evaluate if subjects changed their consumption of milk and bread during the 
study. Vitamin D and calcium intakes from the habitual diet were calculated on the basis of 
consumption frequencies and vitamin D and calcium concentrations in food items given in the 
Danish Food Composition Databank 
(181)
. Vitamin D contributions from the fortified milk and bread 
were calculated on the basis of frequencies of milk and bread consumptions and measured vitamin 
D concentrations in the study milk and bread. The contribution of vitamin D from dietary 
supplements was calculated as the frequency of use times the self-reported content of vitamin D in 
the supplement used. 
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The FFQ was adapted from an FFQ used in the European Union project Towards a strategy for 
Optimal Vitamin D Fortification 
(75)
. The composition of the questions was adjusted the present 
study with self-administration and Web-based setup. The necessity of food groups in relation to 
their vitamin D contribution in the target group was evaluated, and it was decided to add fats and 
cold meat. The FFQ included the following food categories: milk, milk products, cheese (on top of 
bread and as part of a dish), bread, eggs, cold meat, poultry, meat, offal, fish (on top of bread and as 
part of a dish) and fats (on top of bread and used for cooking). As the recording of the participants´ 
bread intake was important and as bread may be consumed several times a day, the eleven 
frequency categories covered from never to >8/day. Portion sizes were estimated in collaboration 
with an experienced Dietician. 
The ease ability of the Web-based setup and understand ability of the FFQ was pilot-tested among 
colleagues and friends with no prerequisite in dietary assessment. No major adjustments were made 
hereafter. The FFQ was evaluated with a simple record covering the food groups in the FFQ 
combined with weighing of fish and meat in the main meal in 49 of the participating children. The 
frequencies of milk and rye bread consumption were overestimated in the FFQ compared with the 
daily registering whereas the frequencies of meat and cheese in the main meal were underestimated 
(182)
. Portion sizes were overestimated in the FFQ compared with the weighted portion sizes in the 
4-7 year-old children. 
Compliance to the intervention was registered 4 times during the study. In a short self-administered 
Web-based questionnaire, subjects reported their consumption of milk and bread other than the 
products provided in the study. Compliance was estimated by dividing the number of portions of 
milk or bread consumed per day other than the products provided in the study by the total number 
of portions of milk or bread consumed per day as reported in the FFQ. 
 
3.5 Examination and blood collection 
Subjects were examined, and blood samples were collected, in an authorized laboratory 
(Copenhagen´s General Practitioners Laboratory). Weight was measured to the nearest 0.1 kg in 
normal clothes without shoes (1 kg was withdrawn from the measured weight) by using a body-
composition analyzer (Tanita BC-418; Tanita Europe BV). Height was measured to the nearest 
centimeter without shoes by using an ultrasonic height measure (Soehnle 5001; Soehnle 
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Professional GmbH & Co). BMI (in kg/m
2
) was calculated on the basis of measured weight and 
height, and subjects were categorized into normal weight, overweight and obese classes according 
to standards for children 
(183) 
and the World Health Organization International standard for adults 
(184)
. Local anesthetic patches were offered to the children before blood sampling. A trained 
biomedical laboratory technician drew nonfasting venous blood samples from subjects. Blood 
samples were held at room temperature for 30 min before centrifugation (1800×g for 10 min), and 
serum and plasma were collected and stored at -80 °C until analysis. 
 
3.6 Biochemical analyses 
All blood samples were analyzed as single determinations in a random order at the Clinical 
Biochemical Department, Holbæk Hospital, Denmark, after completion of the study. Measurements 
of serum 25(OH)D concentration relied on the determination of both 25(OH)D2 and 25(OH)D3 and 
were conducted by isotope-dilution liquid chromatography-tandem mass spectrometry (LC/MS-
MS) by using principles described elsewhere 
(185)
. The standard reference material vitamin D in 
human serum (SRM 972) 
(68) 
was used as the primary calibrator. In DEQAS, the mean bias for our 
method compared with the mean of the DEQAS LC-MS group during the period of the present 
analyses was -3.2 %. Interassay CVs for our method were 2.2 % and 2.8 % at 30 and 180 nmol/L, 
respectively, for 25(OH)D3 and 7.6 % and 4.6 % at 43 and 150 nmol/L, respectively, for 25(OH)D2. 
Serum total calcium (CV: 1.2 %) was measured by using a chemistry analyzer Cobas c501 (Roche 
Diagnostics), and plasma PTH (CV: 3.4 %) was measured by using an immunology analyzer Cobas 
e601 (Roche Diagnostics) following standard procedures from the manufacturer. 
 
3.7 Statistics 
Due to the study design and logistics, we wanted an equal number of families in the control and the 
fortification group within each of the three distribution supermarkets. Therefore the random 
allocation was stratified by distribution supermarket, the number of female and male children and 
adults in the family, use of multivitamin supplements and week of blood sampling by using the 
minimization method 
(186)
. 
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Mixed models with family as a random factor were applied in all the statistical analyses to account 
for the familial component. When the effect of the fortification was analysed (paper 1), the model 
included age, gender, baseline serum 25(OH)D concentration and treatment group as categorical 
variables and final serum 25(OH)D concentration as the outcome. When the determinants of serum 
25(OH)D concentration at baseline were identified (paper 2), variables significant (P < 0.05) in 
their simple models were included in the multiple model together with age and gender as fixed 
variables and baseline serum 25(OH)D concentration as the outcome. The strength of the familial 
component was considered by calculating the intra-class correlation for each model. The closer the 
value is to 1 the more alike are the subjects within a family with respect to vitamin D status. The 
relationship between total vitamin D intake and serum 25(OH)D concentration (paper 3) was fitted 
with both linear and non-linear models. Possible effect modifiers (age, gender, BMI class and 
baseline serum 25(OH)D concentration) were included in the model each at a time to see their 
influence on the relationship. 
Further details on the statistical analyses are described in each paper. 
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4 Results 
Below is given a summary of the results. Details are found in the three papers.  
The majority of the study population was of normal weight according to their BMI class (94 % of 
the children and 55 % of the adults), and the genders were evenly distributed in both children and 
adults and between the treatment groups (Table 3). The median dietary vitamin D intake was 
similar across age groups (range 2.3-2.6 µg/day) and around 30 % reported multivitamin use both in 
summer and winter (41 % of the children and 25 % of the adults). During summer, 48 % had a sun 
vacation abroad and 23 % had a sun vacation during winter. Approximately half of the adults had a 
medium-long to long higher education, and their lifestyles were generally healthy. 
Table 3. Characteristics of subjects in the fortification and control group. 
 Fortification group Control group 
Gender [n (%)]   
     Female 179 (50) 193 (52) 
     Male 176 (50) 178 (48) 
Age [n (%)]   
     4-10 year 80 (23) 83 (22) 
     11-17 year 74 (21) 84 (23) 
     18-40 year 106 (30) 86 (23) 
     41-60 year 95 (27) 118 (32) 
BMI [n (%)]   
     Normal weight 258 (73) 262 (71) 
     Overweight 75 (21) 80 (22) 
     Obese 22 (6) 29 (8) 
Vitamin D intake1 (µg/day)   
     Habitual diet 2.4 (1.6, 3.4) 2.2 (1.4, 3.1) 
     Fortified milk and bread 6.8 (4.2, 9.5) 0 
     Total from foods 9.2 (7.0, 12.3) 2.2 (1.4, 3.1) 
     Dietary supplements2 3.6 (2.0, 7.1) 3.6 (2.1, 7.1) 
Multivitamin users [n (%)]   
     Summer 244 (32) 
     Winter 105 (30) 109 (29) 
Sun vacation [n (%)]   
     Summer 363 (48) 
     Winter 100 (28) 70 (19) 
1
Median (SD). 
2
Supplement users only. 
At baseline of the study (late summer) the individual serum 25(OH)D concentrations ranged from 
9.3 to 161.9 nmol/L with an overall geometric mean (IQR) of 72.1 (61.5-86.7) nmol/L. There was 
no overall age (P=0.190), gender (P=0.332) or age and gender (P=0.223) differences (paper 2). In 
the adults, geometric mean PTH concentration (95 % CI) for the 25(OH)D groups of <25, 25-49, 
50-75 and >75 nmol/L was 59·8 (43.2-82.8), 39·9 (35·8, 44·3), 36·2 (34·3, 38·2) and 32·7 (31·1, 
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34·4) ng/L (P trend<0.001). The same trend was seen in children aged 4-10 years (P trend=0.012), 
but not in children aged 11-17 years (P trend=0.067). 
In the multiple analysis of all subjects (paper 2) serum 25(OH)D was negatively associated with 
BMI (P<0.001) and positively associated with dietary vitamin D (P=0.008), multivitamin use 
(P=0.019), solarium use (P=0.006), outdoor stay in light clothes (P=0.001), sun preference 
(P=0.002) and sun vacation (P<0.001). When children and adults were analysed separately serum 
25(OH)D was only associated with gender, outdoor stay in light clothes and sun vacation in the 
children. In the adults the associations remained the same as in the model with all subjects but the 
significances for dietary vitamin D, multivitamin use and sun vacation were weakened. In the 
further exploration of the adults serum 25(OH)D concentration was not associated with lifestyle 
related factors when these were included in the multiple analysis together with the vitamin D source 
related variables. 
The intra-family correlation was calculated from these multivariate models to assess the strength of 
the familial component. It was 0.27 in all subjects, 0.42 in children and 0.24 in adults, thus children 
within a family seemed to be more alike than adults within a family with respect to their vitamin D 
status (paper 2). 
At baseline, there was no difference between the treatment groups in the prevalence of serum 
25(OH)D <30 nmol/L (P=0.158) and <50 nmol/L (P=0.814) (paper 1). By the end of the study, 
<1% of subjects in the fortification group compared with 25 % of subjects in the control group had 
25(OH)D concentrations <30 nmol/L (P <0.001), and 16 % of subjects in the fortification group 
compared with 65 % of subjects in the control group had 25(OH)D concentrations <50 nmol/L (P 
<0.001) (Figure 6). 
In the adult fortification group, 25(OH)D decreased from months 0 to 3 (P<0.001) and increased 
from months 3 to 6 (P=0.014); nevertheless, the final concentration was lower than the baseline 
concentration (P <0.001). In the adult control group, 25(OH)D decreased from months 0 to 3 
(P<0.001) and continued decreasing from months 3 to 6 (P=0.001). In the children, 25(OH)D 
decreased from months 0 to 6 in both the fortification and control groups (both P<0.001) (Table 3). 
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Figure 6. Prevalence of subjects with serum 25(OH)D concentration <30 and <50 nmol/L at baseline (month 0) and by 
the end of the study (month 6). 
*
Significant difference between fortification and control group (P<0.001). 
 
The final serum 25(OH)D concentration for all subjects was significantly higher in the fortification 
group (67.6 (56.2, 79.4) nmol/L) compared with in the control group (41.7 (29.5, 58.9) nmol/L) 
despite that 25(OH)D decreased in both groups (-5.5 and -29.4 nmol/L) (P<0.001, interpreted 
estimate 1.59, linear mixed model) (paper 1). Additional adjustment of the model for BMI 
(P=0.782) multivitamin usage (P<0.001) and sun vacation (P<0.001) did not change the magnitude 
of the effect of treatment (P<0.001, interpreted estimate 1.58). 
 
Table 3. Biochemical measures in children and adults in the fortification and control group at month 0, 3 and 6
1
. 
 Children 4-17 years   Adults 18-60 years  
 Fortification group 
(n=154) 
Control group     
(n=167) 
P  Fortification group 
(n=201) 
Control group 
(n=204) 
P 
25(OH)D (nmol/L)        
     month 0 72.8 (64.0, 88.9) 72.8 (61.8, 83.9) 0.524  73.3 (61.9, 88.3) 70.0 (60.0, 86.7) 0.286 
     month 3 - - -  63.1 (52.5, 77.6) 44.7 (32.4, 63.1) <0.001 
     month 6 67.6 (56.2, 79.4) 42.7 (30.9, 58.9) <0.001  66.1 (56.2, 79.4) 40.7 (28.8, 60.3) <0.001 
PTH (ng/L)        
     month 0 35.0 (28.8, 41.5) 35.3 (27.6, 43.3) 0.969  35.5 (27.8, 44.2) 34.2 (26.9, 41.4) 0.268 
     month 6 36.3 (27.5, 47.9) 41.7 (32.4, 52.5) 0.028  36.3 (29.5, 45.7) 38.9 (30.9, 46.8) 0.049 
Total calcium (mmol/L)        
     month 0 2.45 (2.40, 2.49) 2.47 (2.42, 2.51) 0.035  2.43 (2.37, 2.47) 2.43 (2.37, 2.49) 0.268 
     month 6 2.45 (2.40, 2.50) 2.45 (2.40, 2.50) 0.428  2.42 (2.37, 2.46) 2.41 (2.36, 2.47) 0.423 
1
Values are geometric means (IQR). P-values are for the comparison of treatment groups in biochemical measures at 
each time point. 
 
The final PTH concentration was lower in the fortification group than in the control group in both 
children and adults, whereas there was no difference in final total calcium concentrations between 
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treatment groups. The combined analysis of children and adults in linear mixed models adjusted for 
baseline values of the endpoint, gender and age showed a treatment effect on PTH (P<0.001, 
interpreted estimate 0.91) and no treatment effect on total calcium (P=0.237). 
During the study, daily median (IQR) milk consumptions were 532 (262, 712) mL in the children 
and 266 (139, 563) mL in the adults. Daily bread consumptions were 117 (80, 164) g in the children 
and 101 (63, 157) g in the adults (paper 1). The planned fortification strategy was to increase the 
vitamin D intake from foods to 7.5 µg/day. This succeeded in 66 % of the subjects in the 
fortification group with a median (IQR) intake of 9.2 (7.0, 12.3) µg/day compared with 2.2 (1.5, 
3.0) µg/day in the control group. With contributions from dietary supplements, the median total 
vitamin D intake was 14.7 (10.6, 18.2) µg/day in supplement users in the fortification group and 6.2 
(4.1, 9.0) µg/day in supplement users in the control group (paper 3).  
The relationship between total vitamin D intake from natural foods, fortified foods and dietary 
supplements and the serum 25(OH)D concentration was best fitted by a log-model yielding a non-
linear curve (Figure 7).  
 
 
Figure 7. Models for the relationship between total vitamin D intake and serum 25(OH)D concentration (n=692). 
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The effect of the total vitamin D intake on serum 25(OH)D concentration was modified by gender 
(P = 0.014) and initial 25(OH)D group (P<0.001), but not by age group (P=0.132) or BMI class 
(P=0.884) (paper 3). For each doubling of vitamin D intake, 25(OH)D in men increased by 4 % 
more than in women, and vitamin D intake had a 10 % higher effect on participants with lowest 
initial 25(OH)D than on participants with highest initial 25(OH)D. Estimated total vitamin D 
intakes of 5, 11, 23 and 39 µg/day were required to maintain a winter vitamin D status above 50 
nmol/L in 50, 75, 90 and 95 % of the population. These figures were higher for the group with 
lowest initial 25(OH)D concentration and lower for the group with highest initial 25(OH)D 
concentration (Table 4). 
 
Table 4. Estimated vitamin D intake to maintain serum 25(OH)D concentration >25 and >50 nmol/L 
in specified proportions of the population and for the four initial 25(OH)D groups (n=688). 
Vitamin D intake (µg/day) 97.5 % limit 95 % limit 90 % limit 75 % limit 50 % limit 
Aim >50 nmol/L      
Overall  39 23 11 5 
Initial <61.5 nmol/L - - 34 18 11 
Initial 61.5-73.4 nmol/L - 37 22 1 6 
Initial 73.4-86.9 nmol/L - 37 19 7 4 
Initial >86.9 nmol/L 39 17 8 3 <1 
      
Aim >25 nmol/L      
Overall 6 4 3 1 <1 
Initial <61.5 nmol/L 11 7 5 3 2 
Initial 61.5-73.4 nmol/L 7 4 3 2 <1 
Initial 73.4-86.9 nmol/L 4 2 <1 <1 <1 
Initial >86.9 nmol/L <1 <1 <1 <1 <1 
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5 Discussion 
5.1 Vitamin D status 
Vitamin D status in the Danish children and adults by the end of the summer was >50 nmol/L with 
a mean of 72.1 nmol/L (paper 2). During winter serum 25(OH)D concentration remained above 
this limit in the majority (84 %) of children and adults receiving the vitamin D fortified milk and 
bread with a mean of 67.6 nmol/L whereas the prevalence >50 nmol/L decreased to 35 % in the 
control group with a mean of 41.7 nmol/L (paper 1). The found vitamin D status both in summer 
and winter and the prevalence >50 nmol/L were generally higher than previous findings in similar 
age and ethnicity groups in Denmark 
(72-75) 
and other countries 
(75, 78-87)
. These differences could be 
attributed differences in dietary habits, use of dietary supplements, sun habits, lifestyle, socio-
economic status and composition/characteristics of the study population. For example most of our 
subjects were of normal weight which could favourable impact the serum 25(OH)D concentration 
compared with the high rate of obesity in other groups for example in the USA 
(187)
. Another 
explanation would be that the method used in our study (LC/MS) has often been found to yield 
higher results compared with other methods 
(55, 57, 64, 66)
. In DEQAS the LC-MS methods is also 
positively biased for the ALTM whereas the often used immunoassays are mostly negatively biased 
(62)
. However, the LC-MS method might be considered the golden standard 
(55, 57)
, and our method 
was standardized and calibrated against the International reference material by NIST 
(68)
. In a study 
of the German population standardization to the LC-MS/MS method reduced the prevalence of 
vitamin D deficiency (<30 nmol/L) from approximately 48 % to 16 % 
(188)
. Methods are 
continuously improving and standardization and cross-calibration seem to be possible now with the 
NIST standard that was used in the present study. Hopefully this will improve method related 
variability in the future. 
A novelty in the VitmaD study was the quantitatively assessment of the familial component by 
calculation of the intra-class correlation. The intra-family correlation was almost the double in the 
children as in the adults (paper 2), which indicates that the children within a family were more 
alike than the adults within a family with respect to their vitamin D status. This might be an 
indication of the influence of genetic factors on vitamin D status or more similar habits in children 
than in adults from the same family. It is likely that children within a family share activities and 
dietary/supplementation habits to a larger extent than adults within a family. Another speculation 
could be the gender factor with a mother and a father in each family although the statistical analyses 
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did not show a gender difference in vitamin D status in the adults (paper 2). When the children 
were analysed separately, the boys had a statistically higher vitamin D status compared with girls. 
Thus, if one family included two boys or two girls they could be more similar than if the family 
included one of each gender. The apparently greater similarity in vitamin D status in children 
compared with in adults within a family may also be attributed a greater difference in adiposity 
between the adults. This hypothesis was expressed by BMI being negatively associated with serum 
25(OH)D in the adults but not in the children (paper 2). However, BMI did not affect the effect of 
the fortification (paper 1) or the response in 25(OH)D to total vitamin D intake (paper 3). Several 
studies have investigated the relation between adiposity and serum 25(OH)D or the response in 
serum 25(OH)D. The use of BMI as a measure of adiposity in relation to vitamin D status is 
controversial and some studies did not find an association between BMI and 25(OH)D 
(85, 189-193) 
whereas a recent meta-analysis found an inverse relationship between BMI and 25(OH)D 
(194) 
like 
several other studies 
(78, 84, 195-198)
. More direct measures of adiposity such as body fat mass, waist 
circumference and skin folds have also been associated with serum 25(OH)D or its response to 
supplementation 
(195, 196, 199-201) 
and might be alternative predictors of vitamin D status. Several 
mechanisms have been suggested for the apparently lower serum 25(OH)D levels associated with 
obesity and one explanation could be sequestration of vitamin D in fat tissue 
(198)
. Although there is 
limited evidence, it has been speculated if low serum 25(OH)D levels may predispose to obesity 
rather than the obesity in itself predisposing for low serum 25(OH)D levels 
(199, 202, 203)
. 
Vitamin D status in late summer was both associated with sun exposure factors (sun behaviour, 
outdoor stay in light clothes, sun vacation and solarium use), intake from the diet and use of 
multivitamins (paper 2). This finding substantiates the relevance of dietary intakes in addition to 
sun exposure not only during winter. Most suggestive may be that vitamin D status was associated 
to sun vacation (abroad) despite that the hours of sunshine the preceding summer (2010) in 
Denmark was only slightly below (3 %) the average hours of sunshine for the preceding ten years 
(204).
 To our knowledge, this association between vitamin D status and sun vacation during summer 
season has not been shown previously. 
After all, what is actually the optimal serum 25(OH)D concentration? And optimal for what? A 
serum 25(OH)D concentration of 50 nmol/L was considered sufficient for bone health in the NNR 
(103) 
and by the US Dietary Committee 
(47)
. Some argue that 25(OH)D concentrations in the interval 
75-125 nmol/L should provide the benefit of vitamin D while limiting the risk of potential harm  
(95, 
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98, 104-106)
 based on the associations of serum 25(OH)D with functional markers or the incidence of 
certain diseases 
(25, 41)
. For example PTH is a surrogate marker of bone resorption in adults 
(100)
. We 
found a negative trend between PTH and serum 25(OH)D groups in the adults and in the children 
aged 4-10 years (paper 2). However, a comprehensive review of the health effects of vitamin D and 
calcium concluded that the evidence for non-skeletal effects of vitamin D was inconclusive 
(205)
. In 
a socio-economic perspective it has been estimated that a 10-50 % reduction in specific disease 
rates, a 17-18 % reduction in mortality rates (range for Denmark 11-24 %) and a 2-3 year increase 
in life expectancy could be possible by increasing the population mean serum 25(OH)D 
concentration to 100-105 nmol/L and thereby the economic burden of disease would be reduced 
(206-
209)
. However, the causality remains yet unproven in randomized controlled trials (RCT) 
(210)
. 
Studies have associated 25(OH)D concentrations with socio-demographic and lifestyle related 
factors 
(78, 211) 
and thus it might be that vitamin D is simply a marker of general lifestyle/health. I 
find it plausible that there might be extra-skeletal functions of vitamin D that we do not know a lot 
about yet, but I am skeptic about the unnatural high serum 25(OH)D concentrations that have been 
suggested which would be difficult to meet by a normal lifestyle.  
Another question is if vitamin D status should be constant year-round? We still do not know the 
impact of seasonal fluctuations in vitamin D status and what it means for long-term health that a 
significant part of the population has a vitamin D status between 25 and 50 nmol/L during winter. It 
might be that people at Northern latitudes have adapted to these circumstances 
(24)
, so that some 
decline in serum 25(OH)D concentration during winter is acceptable and that a chronically low 
concentration is the condition more critical for long-term health.  
 
5.2 Vitamin D intake 
As well as optimal vitamin D concentrations are discussed, there is little agreement on the intake 
needed to maintain a specified vitamin D status year-round. It is complicated by the fact that 
vitamin D is provided by both endogen synthesis and intakes. The contribution of vitamin D from 
fortified foods resulted in a total vitamin D intake of 14.7 µg/day in dietary supplement users and 
9.6 µg/day in non-users (paper 3) and maintained serum 25(OH)D concentration above 50 nmol/L 
in 84 % of the subjects with usual supplementation and sun vacation habits during winter in 
Denmark (paper 1). The corresponding figure from the dose-response relationship between total 
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vitamin D intake and serum 25(OH)D concentration was 11-23 µg/day for 75-90 % of the 
population (paper 3). This estimated required intake was increased to 39 µg/day if 95 % of the 
population should meet the goal of 50 nmol/L, which is higher than the new RI of 10 µg/ that is 
based on 97.5 % of the population. It was also higher than previous estimates in children, adults and 
elderly 21.8 
(193, 212, 213)
. Interestingly, a meta-analysis found that a vitamin D intake of only 9-12 
µg/day was needed to sustain 97.5 % of the population above 50 nmol/L during winter 
(214)
. Based 
on calculations of the metabolic clearance of 25(OH)D, a study estimated that an intake of 12.5-
17.5 µg/day was sufficient to maintain serum 25(OH)D at 50 nmol/L 
(211)
. The estimated required 
vitamin D intake was lower for the group with highest initial vitamin D status compared with the 
group with lowest initial vitamin D status. Thus, our results support the concept of initial vitamin D 
status and/or cutaneous synthesis during the summer probably offsets the dietary requirement for 
vitamin D during winter 
(193, 212)
. Our calculation of required vitamin D intake for different levels of 
initial vitamin D status is novel in relation to previous studies that have found the initial vitamin D 
status to be associated with the response in 25(OH)D 
(192, 215, 216)
. 
In the VitmaD study the relationship between total vitamin D intake and status was best fitted by a 
non-linear curve (paper 3) similar to previous observations 
(189, 191, 205, 212, 214, 215, 217)
. Others have 
reported response estimates based on linear analyses 
(49, 53, 164, 191, 193, 213, 214, 218-221)
. When 
considering required vitamin D intake in populations for example in the setting of dietary 
recommendations, the effect in serum 25(OH)D per microgram of ingested vitamin D is often 
considered. In a meta-analysis of the efficiency of vitamin D fortified foods in adults the effect was 
evaluated as the difference between the treatment groups in their 25(OH)D change in relation to the 
vitamin D intake from the fortification 
(219).
 The treatment effect was 1.2 nmol·L
-1
·µg
-1
, which is 
lower than our finding of 3.4 nmol·L
-1
·µg
-1
 (paper 1). In studies with dietary supplements the effect 
has been calculated as the change in 25(OH)D or the final 25(OH)D as a function of vitamin D 
dose. These studies yielded constants of 0.4-5.0 nmol·L
-1
·µg
-1
 
(49, 53, 190, 191, 217, 218, 222)
. Thus, the 
figures are calculated by different means which should be kept in mind when using the figures for 
discussion of required vitamin D intake. Systematic reviews also concluded that studies were 
heterogeneous in their design, population and 25(OH)D assay 
(205, 214, 220) 
which may contribute to 
observed differences between studies. 
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5.3 Fortification model and its effects 
The fortification strategy in the current study resulted in a higher serum 25(OH)D concentration in 
the fortification group (67.6 nmol/L) compared with the control group (41.7 nmol/L) at the end of 
the winter season, despite the fact that 25(OH)D decreased in both groups during the study (-∆5.5 
nmol/L in the fortification group and -∆29.4 nmol/L in the control group) (paper 1). The planned 
fortification strategy was to increase the vitamin D intake to the amount of 7.5 µg/day 
recommended in the NNR at that time 
(131)
. This strategy succeeded in 66 % in the fortification 
group. A difference in our results compared with most of the previous fortification studies was that 
the beneficial effect was expressed as a reduction in the seasonal decline in 25(OH)D compared 
with in the control group. Our observations were similar to those of 2 other RCTs in 17-54 year old 
men and women with baseline 25(OH)D and fortification amounts comparable to those in our study 
(102, 221).
 Most previous studies had a lower initial starting point than that of our study and observed 
an increase in 25(OH)D after supplementation with vitamin D fortified foods 
(159-162, 164, 167-169, 171, 
172, 175, 177)
. An important conclusion from systematic reviews was the large heterogeneity between 
fortification studies 
(205, 220)
. The studies varied in design, study population, baseline 25(OH)D, food 
vehicle used, and fortification amounts. Therefore, the treatment effects could not be directly 
compared and should be interpreted with caution. A novelty in the design of the current study was 
the combined use of two food vehicles consumed during the day according to the participants´ usual 
habits. This design was different from that in the previous studies which used single vitamin D 
fortified foods, mostly milk but also yoghurt drinks, cheese, orange juice and bread consumed in a 
predefined serving or amount 
(102, 159-162, 164, 165, 167-169, 171, 172, 175, 177)
. 
This research demonstrated that a targeted vitamin D food fortification is an efficient way to 
improve vitamin D intake and status in the general population. The combination of fortified milk 
and bread proved suitable for 4-60 year-old Danes, partly because Danish children and, to some 
extent, adults drink more milk than do other population groups. Milk is not widely consumed in all 
populations, whereas bread is a primary food in many countries. Therefore, the present study 
suggested that including bread in the current selection of vitamin D fortified foods could be an 
effective way to attenuate seasonal fluctuations in vitamin D status. Others have investigated the 
effect of fortifying single food items with vitamin D (references). These were mostly dairy products 
but also orange juice and bread have been investigated. Orange juice may not be consumed on a 
regular basis and there might be large variations in the amounts of milk consumed in different 
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groups so that the vitamin D intake becomes skewed. Bread in different forms is a food that is 
consumed daily for most people. Vitamin D can be added the flour like in this study as well as 
during baking like in a previous study 
(160)
. An important finding in the present study was that the 
analyses of bread did not fully recover all of the added vitamin D. We suspect that some of the 
vitamin D was lost during baking. This loss was unexpected because, in a previous fortification 
study, the added vitamin D was recovered in both dough and baked wheat and rye breads 
(160)
. 
The present study is an example of modelling on usual food consumptions that can be applied in 
other populations as well. It is recommendable as the current diffuse fortification practices in many 
countries do not seem optimal to improve vitamin D status in the general population 
(127, 155, 156)
. It is 
a political decision if the fortification should be on a voluntary or mandatory basis. The voluntary 
solution gives the consumers a choice to select or deselect fortified products, whereas the 
mandatory approach targets the entire population. It is often the most vulnerable groups that have 
the need for supplementation and they are targeted with mandatory food fortification. 
The dose-response study (paper 3), however, showed that the required vitamin D to maintain 
vitamin D status above 50 nmol/L in the majority of the population should be higher than the new 
RI 
(130).
 If this is actually the case, then the fortification concentrations should also be higher than 
those applied in the study. On the other hand, it can be discussed how large a proportion of the 
population the fortification strategy should target as the dose-response study also showed that the 
required vitamin D intake during winter varied largely between the selected proportion of the 
population (5-23 µg/day for 50-90 % of the population) and was dependent on the initial vitamin D 
status. When the present study was designed, the fortification concentrations should be effective 
without possessing a risk for any of the subjects reaching an intake above the UL. Since that time, 
the UL has been doubled 
(52) 
thus allowing for a greater interval for fortification. However, having 
the opportunity to do it is not the same as it is reasonable to do it.  We still do not know the long-
term effects of prolonged higher vitamin D intakes 
(49)
, and it is relevant to discuss how precaution 
in a future fortification model should be considered. The aim with a fortification strategy is to move 
the distribution curve for vitamin D intake towards right. It is just a question about how far it should 
be moved. Those with the most need (the left of the distribution curve) is benefited, but the vitamin 
D intake in those with the least need (the right part of the distribution curve) is also increased and 
moved closer to the UL. Do we want as large a proportion of the population as possible to have the 
recommended intake or higher? or just the median? Should a fortification strategy ensure a 
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minimum intake in all thus ensuring no severe deficiency rather than securing the optimal? Should 
the better part be protected against high intakes although they are not close to the UL? 
Generally, it is a relevant discussion how to improve vitamin D intake and status in the population 
and if it is really needed. It is suggestive that the RI for vitamin D in the NNR has gone from 5 to 
7.5 to 10 µg/day from 1996 to 2012 thus being doubled over 16 years. Have we gained that much 
new knowledge? Have our sun exposure behaviours changed that much so the dietary intake should 
be doubled? Then I question: Is it the recommendations that are set too high in relation to what is 
actually needed? Or is the intake too low in relation to the need? 
 
5.4 Considerations about the study design 
It is a challenging task to execute RCTs in a real-life setting and it is the art of balancing control, 
restriction and the wish of not to interrupt the natural behaviour of subjects. As with all other 
studies, it is also a balance between how demanding it can be for the subjects and the information 
you want to collect as well as the time frame and budget are important for what is feasible. If the 
demands are too high it can be difficult to recruit subjects and the ones you get might be the very 
dedicated and health-aware people. We wanted a sample of typical Danish families with children 
and minimal interruption of their daily life and therefore we had few inclusion criteria and 
restrictions. On the other hand, when approaching real-life, there is a chance of the intervention 
effect being blurred by confounders. 
When designing the fortification study, several points were considered such as: how to deliver fresh 
milk and bread to 800 persons through a half year? How to minimize the interruption of the 
subjects´ daily life? How to monitor the subjects? How to register their food intake and 
compliance? 
As children families usually have busy week days and as they were going to participate in the study 
for a relatively long period, we wanted the distribution of milk and bread to be easy for the subjects. 
This was logistically challenging as we also wanted the milk and bread to be fresh instead of for 
example frozen. The solution with distribution through three local supermarkets worked well with 
minimal issues and eased the participation for the families as they could pick up their study 
 35 
 
products while doing their usual grocery shopping. Due to this logistics, a minor limitation of the 
study was that it was conducted at a single site in Denmark.  
A motivation factor for the families was the free food. They said that it was “a nice offer” with free 
milk and bread through six months which might have been a large saving for some families. Others 
were interested in vitamin D and had previously been diagnosed with vitamin D deficiency and 
experienced symptoms during the winter. Therefore they wanted to see if fortification could help 
them improving their vitamin D status. Some of the families stated that they felt specially selected. 
We believe that the family and real-life based design was one of the main reasons for the low 
dropout rate and high compliance. Informal feedback from subjects indicated that they made their 
participation a joint family project, which they could discuss at dinner times, and they encouraged 
and reminded one another to consume the study products provided. Thus, the results confirmed our 
assumption that it would ease the compliance to the intervention if the whole family participated 
instead of just one member of the family as it interrupts the routines less. The family-based design 
also ensured a broad spread of age and gender in both children and adults and it eased the 
recruitment of many subjects. 
However, it might also be more challenging to adjust the information and to collect and use data on 
an individual level in diverse groups. For example, how differentiated should the information 
material be? Do you want the same information for children and adults? Which information do you 
need for each of the groups for example tanner stage in children and lifestyle in adults. Do you want 
the questionnaires to be differentiated or do you want them to use the same questionnaire? Or 
should it only be targeted the parents? Do you want the information to be addressed each of the 
family members or only one from the family? Should the family be examined at the same time or at 
different times? It was a balance between what was practically durable and what was wanted for the 
study design. For example the family could not start consuming the study products before all the 
family members had their blood drawn, but for some of them it was difficult to manage blood 
sampling the same day. 
We decided to keep it simple and therefore we developed one questionnaire and FFQ as the basis. 
Some of the questions were then taken out for the children for example smoking habits and 
occupation. The same FFQ was used for children and adults including the use of portion sizes 
although portion sizes might be different for different age and gender groups. Evaluation of the FFQ 
also showed that the portion sizes were overestimated for the smallest children. The recording of the 
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compliance and how much the subjects had consumed of the study products was also challenging as 
the subjects should consume the milk and bread during the whole day according to their usual habits 
instead of consuming them in fixed amounts. It would have been too demanding for the subjects to 
register their milk and bread consumption every day during a half year. Instead we asked them to 
register their consumption of milk and bread other than what was given in the study in a frequency 
format. That resulted in a roughly estimate of the compliance which was considered sufficient in 
this study. We could also have given them a record covering a few days, but we did not want to put 
focus on their consumption so that the possibility of influencing their usual dietary pattern was 
opened. 
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6 Conclusion and perspectives 
Serum 25(OH)D concentration in children and adults in late summer in Denmark were above 50 
nmol/L in the majority with no overall differences between gender and age groups. Both dietary and 
sun related factors as well as BMI were determinants of vitamin D status, and the familial 
component was stronger for the children than for the adults. Vitamin D fortification of milk and 
bread, to an amount that increased the intake to recommended amount, reduced the decrease in 
serum 25(OH)D concentration during winter and  maintained 25(OH)D above 50 nmol/L. The 
relationship between total vitamin D intake from natural foods, fortified foods and dietary 
supplements and serum 25(OH)D concentration was non-linear. Estimated required total vitamin D 
intake to maintain 25(OH)D above 50 nmol/L during winter was largely dependent on the initial 
vitamin D status. The family-based approach showed to be a good way to heighten compliance and 
ease the inclusion of a broad age group of both genders. 
Overall, the present study demonstrated that it is feasible to conduct RCTs in real-life settings 
without compromising the quality of the study and the chance to see an effect of the intervention. 
Furthermore, the study showed the use of model data from usual food-consumption intakes to 
establish an effective fortification strategy targeted at the intended population. The investigated 
fortification model was efficient in a population of Danish families. It is possible that the response 
to the fortification would have been different in other population groups such as elderly or dark-
skinned groups. These groups would probably have a lower initial vitamin D status than the 
families in the VitmaD study, and it is likely that a fortification strategy with bread would also work 
in these groups. This could be investigated. If implementation of the fortification strategy was 
mandatory, the choice of using fortified products or not could not be influenced by factors such as 
age, gender, education, social status and ethnic affiliation. It would be a matter of the consumer 
eating the type of fortified product or not and the frequency of consumption. The results are likely 
to be generalizable, and including bread in the current selection of vitamin D fortified foods could 
be an effective way to improve vitamin D status of the general population. 
The stability of vitamin D in different types of bread should be further investigated, and the 
fortification model should be adjusted to the new RI in the NNR for future applications. Other foods 
could be considered for fortification, and awareness on how to ensure safety is recommended, not 
only in relation to the UL. 
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Randomized controlled trial of the effects of vitamin D–fortified milk and
bread on serum 25-hydroxyvitamin D concentrations in families in
Denmark during winter: the VitmaD study1–3
Katja H Madsen, Lone B Rasmussen, Rikke Andersen, Christian Mølgaard, Jette Jakobsen, Poul J Bjerrum,
Elisabeth W Andersen, Heddie Mejborn, and Inge Tetens
ABSTRACT
Background: Vitamin D intakes are lower than dietary recommen-
dations in most populations, and thus, a low vitamin D status is
widespread, especially during winter.
Objective: We investigated the effects of increasing vitamin D in-
take to the recommended amount by fortification of milk and bread
on serum 25-hydroxyvitamin D [25(OH)D] concentrations in fam-
ilies during winter in Denmark.
Design: The study was a randomized controlled trial in 782 children
and adults (4–60 y old) recruited as 201 families. Families were
randomly assigned to vitamin D–fortified or nonfortified milk and
bread for 6 mo starting in September. The milk and bread replaced
the participants’ usual consumptions of products.
Results: Median (IQR) vitamin D intakes (habitual diet plus forti-
fied products) were 9.4 mg/d (6.5, 12.3 mg/d) and 2.2 mg/d (1.5, 3.0
mg/d) in fortification and control groups, respectively. Geometric
mean (IQR) serum 25(OH)D concentrations decreased from 73.1
nmol/L (61.9, 88.5 nmol/L) to 67.6 nmol/L (56.2, 79.4 nmol/L) in
the fortification group and from 71.1 nmol/L (61.2, 85.9 nmol/L) to
41.7 nmol/L (29.5, 58.9 nmol/L) in the control group (both P ,
0.001). The final 25(OH)D concentration was significantly higher in
the fortification group than in the control group (P , 0.001). By the
end of the study,,1% of subjects in the fortification group and 25%
of subjects in the control group had 25(OH)D concentrations ,30
nmol/L and 16% and 65% of subjects, respectively, had 25(OH)D
concentrations ,50 nmol/L.
Conclusion: Vitamin D fortification of milk and bread reduces
the decrease in serum 25(OH)D concentrations during winter and
ensures 25(OH)D concentrations .50 nmol/L in children and
adults in Denmark. This trial was registered at clinicaltrials.gov
as NCT01184716. Am J Clin Nutr 2013;98:374–82.
INTRODUCTION
At latitudes above 408N, vitamin D is not synthesized in the
skin during the winter (1) and therefore, the vitamin D supply
during this period depends on dietary intakes. Relatively few
foods contain vitamin D (2) naturally, and vitamin D intakes are
lower than dietary recommendations in most populations (3–5).
Consequently, vitamin D deficiency is a public health concern in
many countries (6–10).
The recently updated American dietary reference values for
vitamin D from the Institute of Medicine (11) have stimulated
scientific debate about the effects of different strategies to
improve vitamin D status, which is measured as circulating
25-hydroxyvitamin D [25(OH)D]4 concentrations (12), at the pop-
ulation level. Food fortification is one preventive strategy to reach
the entire population, and several countries fortify milk or mar-
garine with vitamin D. Nonetheless, this fortification practice
does not seem optimal for improving vitamin D status in the general
population because of the skewness of milk intake across population
groups (13, 14). A recently published systematic review emphasized
the need for randomized controlled trials (RCTs) to ascertain the
impact of potential vitamin D food-fortification strategies to ensure
effectiveness at the population level (15). In Denmark, there are few
fortified foods on the market, and thus, this country provides
a unique opportunity to investigate the effects of a fortification
strategy in a real-life environment.
Previous RCTs have investigated the effects of single vitamin
D–fortified foods such as milk (16–24), yoghurt drink (25, 26),
cheese (27, 28), orange juice (29, 30), and bread (31). In all but
2 of these RCTs (24, 27), the foods were shown to be effective
in improving serum 25(OH)D concentrations. However, to reach
the entire population, a strategy has been suggested (32) in which
several food vehicles are fortified at lower amounts rather than one
food item at a higher fortification amount. To our knowledge, no
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previous studies have investigated combinations of fortified foods,
and only a few studies have targeted children (19, 22).
Our strategy was to build a realistic fortification model that
could be used in a real-life setting on the basis of models gen-
erated from high-quality dietary intake data from the Danish
National Survey of Dietary Habits and Physical Activity (33).
The objective of this RCT was to investigate the effects of
increasing vitamin D intake by fortification of milk and bread to
the amount recommended in the Nordic Nutrition Recommen-
dations (NNRs) (34) on serum 25(OH)D concentration in fam-
ilies during a 6-mo winter period in Denmark.
SUBJECTS AND METHODS
Study design
The study was a double-blind, randomized, placebo-controlled
intervention trial with children and adults recruited as families.
An external statistician randomly allocated the families to either
vitamin D3–fortified milk and bread or nonfortified placebo milk
and bread for 6 mo during the winter (September 2010 to April
2011). Milk and bread were distributed to the families 2 times/
wk through 3 local supermarkets. The random allocation was
stratified by the number of female and male children and adults in
the family, use of multivitamin supplements, distribution super-
market, and week of blood sampling by using the minimization
method (35). The milk and bread were blinded by a color and
letter code so that neither the participants nor researchers
knew which products contained vitamin D. A personal iden-
tification card informed each family which supermarket to go
to and obtain products. The card ensured that families received
the correct products and that products were handed out only to
families who were participating in the study. Participants were
instructed to replace their usual consumption of milk and bread
with the products provided in the study. In all other respects, par-
ticipants were requested to live their lives as normal without
changing any habits. The principle in the study design was to in-
vestigate a realistic fortification strategy in a real-life setting. Adult
participants were seen 3 times during the study period (months 0, 3,
and 6), and children (4–17 y old) were seen twice (months 0 and
6). Blood samples were drawn at all 3 visits, and anthropometric
measures were recorded at months 0 and 6. The primary endpoint
was the serum 25(OH)D concentration, and secondary endpoints
were plasma parathyroid hormone (PTH) and serum total calcium.
The study protocol was approved by the Research Ethics Com-
mittee of the Capital Region of Denmark (record H-4-2010-020).
Participants
The sample size was calculated at 88 per group to detect
a mean (6SD) difference in serum 25(OH)D concentration of
11 6 26 nmol/L (21) between treatment groups at the 5%
significance level and with 80% power. To be able to analyze
female and male children and adults separately and allow for
dropouts, we aimed to recruit 800 participants who repre-
sentedw200 families. Participants were recruited in Gladsaxe
Municipality in Denmark (568N) by random withdrawal from the
Danish Civil Registration System. Families with a permanent
address in Gladsaxe and 3–6 members in the household, in-
cluding at least one child aged 4–17 y, were invited by letter
to participate in the study (Figure 1). Inclusion criteria were
age between 4 and 60 y and a permanent address in the
Gladsaxe Municipality. Exclusion criteria were pregnancy
and disease or use of a medication that would influence vi-
tamin D metabolism (including dietary supplements with.10 mg
vitamin D/d for children and .5 mg vitamin D/d for adults,
which corresponded to the typical amounts in multivitamin
supplements in Denmark). There was an ample response to the
letters, and registration was closed after 10 d. At that time, 429
families had responded to the invitation. After screening for
eligibility, 230 families were selected, and invited to an in-
formation meeting. When the families hereafter decided on
their participation, not all members of the household necessarily
participated. All adult participants and custody holders of children
gave their written informed consent to participate, which resulted
in a total of 782 participants (201 families).
Fortification model
The fortification model was built on the following 3 criteria:
the model should include a combination of foods, foods should
be consumed regularly in the chosen age group, and foods
should be low in fat and sugar. On the basis of these criteria,
milk and bread were chosen as foods to include in the model.
The fortification strategy was to increase the vitamin D intake
to 7.5 mg/d as recommended in the NNRs (34) in as many
participants as possible while avoiding an intake above the toler-
able upper intake level [ie, 25 mg/d for children and 50 mg/d for
adults (34)]. The choice of fortification amounts was based on
models generated from dietary intake data from the Danish Na-
tional Survey of Dietary Habits and Physical Activity (7-d con-
secutive dietary record) (33), which took into account the possible
use of multivitamin supplements.
Study milks were organic homogenized 0.5% fat milk pro-
duced by Arla Foods A/S. The fortified milk had a vitamin D3
(cholecalciferol; Kemikalia) concentration w0.38 mg/100 mL,
which was confirmed by analysis in triplicate during the study
period (0.40 6 0.01 mg/100 mL). The placebo milk did not
contain added vitamin D (,0.004 mg/100 mL). Study breads
included white bread, brown bread, rye bread, and buns that
were baked from wheat- and rye-flour blends produced by
Lantma¨nnen Cerealia A/S. Vitamin D3 (cholecalciferol; DSM
Nutritional Products) was added to flour blends to bake fortified
breads. Before and after the study period, samples from 3 different
flour blends of both types were analyzed, and the added vitamin D
was recovered. Twice during the study period, breads of each type
were collected on 3 consecutive baking days and analyzed in pools
of 4 breads. We aimed to produce fortified breads with 6 mg vi-
tamin D3/100 g bread, but the analyses showed a concentration
of 5.2 6 0.3 mg vitamin D3/100 g in the wheat bread and 4.3 6
0.3 mg vitamin D3/100 g in the rye bread. The placebo bread
did not contain added vitamin D. Concentrations of vitamin D
in study milks and breads were analyzed at the National Food
Institute, Technical University of Denmark, by using a reverse-
phase HPLC method described elsewhere (36). Analyses were
accredited according to the standard ISO 17025 (37).
Dietary assessment and compliance
At baseline (month 0), participants completed a self-administered
Web-based questionnaire that assessed their background, health,
and lifestyle and a semi-quantitative food-frequency questionnaire
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(FFQ) that assessed their vitamin D and calcium intakes before the
study. The FFQ was adapted from an FFQ used in the European
Union project Towards a strategy for Optimal Vitamin D Fortifi-
cation (38). By the end of the study (month 6), questionnaires were
repeated to assess eventual changes in health or lifestyle and vitamin
D and calcium intakes during the study. The 2 FFQs were also used
to evaluate if participants changed their consumption of milk and
bread during the study.
Vitamin D and calcium intakes from the habitual diet were
calculated on the basis of consumption frequencies and vitamin D
and calcium concentrations in food items given in the Danish
Food Composition Databank (39). Vitamin D contributions from
the fortified milk and bread were calculated on the basis of
frequencies of milk and bread consumptions and measured vi-
tamin D concentrations in the study milk and bread.
Compliance to the intervention was registered 4 times during the
study. In a short self-administered Web-based questionnaire, par-
ticipants reported their consumption of milk and bread other than
the products provided in the study. Compliance was estimated by
dividing the number of portions of milk or bread consumed per day
other than the products provided in the study by the total number of
portions of milk or bread consumed per day as reported in the FFQ.
Examination and blood collection
Participants were examined, and blood samples were collected,
in an authorized laboratory (Copenhagens General Practitioners
Laboratory). Weight was measured to the nearest 0.1 kg in normal
clothes without shoes (1 kg was withdrawn from the measured
weight) by using a body-composition analyzer (Tanita BC-418;
Tanita Europe BV). Height was measured to the nearest centi-
meter without shoes by using an ultrasonic height measure
(Soehnle 5001; Soehnle Professional GmbH & Co). BMI (in
kg/m2) was calculated on the basis of measured weight and height,
and participants were categorized into normal weight, overweight,
and obese classes according to standards for children (40) and the
WHO International standard for adults (41). Local anesthetic
patches were offered to the children before blood sampling. A
trained biomedical laboratory technician drew nonfasting ve-
nous blood samples from participants. Blood samples were
held at room temperature for 30 min before centrifugation
(1800 3 g for 10 min), and serum and plasma were collected and
stored at 2808C until analysis.
Biochemical analyses
All blood samples were analyzed as single determinations in
a random order at the Clinical Biochemical Department, Holbæk
Hospital, Holbæk, Denmark, after completion of the study.
Measurements of serum 25(OH)D relied on the determination of
both 25(OH)D2 and 25(OH)D3 and were conducted by isotope-
dilution liquid chromatography–tandem mass spectrometry by
using principles described elsewhere (42). The standard refer-
ence material vitamin D in human serum (SRM 972) from the
FIGURE 1. Flow of participants throughout the study.
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National Institute of Standards and Technology (43) was used as
the primary calibrator. The analytic quality of the 25(OH)D
assay was assured by Vitamin D External Quality Assessment
Scheme certification. In this validation scheme, the mean bias
for our method compared with the mean of the Vitamin D
External Quality Assessment Scheme liquid chromatography–
mass spectrometry group during the period of the present analyses
was 23.2%. Interassay CVs for our method were 2.2% and 2.8%
at 30 and 180 nmol/L, respectively, for 25(OH)D3 and 7.6% and
4.6% at 43 and 150 nmol/L, respectively, for 25(OH)D2. Serum
total calcium (CV: 1.2%) was measured by using a chemistry
analyzer Cobas c501 (Roche Diagnostics), and plasma PTH (CV:
3.4%) was measured by using an immunology analyzer Cobas
e601 (Roche Diagnostics) following standard procedures from
the manufacturer.
Statistical analyses
Statistical analyses were conducted with participants who
completed the study and from whom baseline and final bio-
chemical data were obtained (Figure 1). Data were analyzed with
SPSS statistical software (version 20.0; IBM SPSS Inc), and
statistical significance was determined at P , 0.05. Intakes are
presented as medians (IQRs) and biochemical measures as
geometric means (IQRs) unless otherwise stated. Linear mixed
models with the family as a random factor were applied in the
following analyses to account for the nonindependency of the
participants. All continuous variables were log transformed be-
fore analysis to meet model requirements. Eventual changes in
milk and bread consumptions during the study period were
evaluated by testing the difference between the 2 registered
consumptions (months 0 and 6) against the null hypothesis. Like-
wise, in children and adults separately, differences in biochemical
measures [25(OH)D, PTH, and total calcium) between months 0, 3,
and 6 within treatment groups were tested against the null hy-
pothesis to determine eventual changes. Linear trend analyses for
serum 25(OH)D in adults were applied. Treatment groups (chil-
dren and adults separately) were compared for biochemical mea-
sures at the different time points in mixed models with the group
as a categorical variable and serum 25(OH)D as the dependent
variable. Treatment effects on biochemical endpoints were tested
in mixed models adjusted for age and sex (categorical variables)
and for baseline values of the endpoint (covariate). A second
model with the primary endpoint 25(OH)D was further adjusted
for BMI, multivitamin usage, and sun vacation to evaluate the
potential influence on the treatment effect. Interactions between
the group and baseline, group and sex, and group and age were
assessed in the model with 25(OH)D as the endpoint. Binary lo-
gistic regression by using the generalized estimating equation (to
allow for dependence within families) was applied to compare
treatment groups in their prevalence of serum 25(OH)D concen-
trations,30 and,50 nmol/L at baseline (month 0) and at the end
of the study (month 6).
RESULTS
Characteristics and intakes of participants
Of a total of 201 families (782 participants), 6 families (20
participants) and 28 single participants did not complete the study
for various reasons (Figure 1). An additional 8 participants were
excluded from the final analysis because of insufficient blood
collection. Baseline characteristics and intakes are shown in
Table 1.
Neither milk nor the bread consumption changed during the
study (data not shown; P = 0.551 for milk and P = 0.580 for
bread). Daily median (IQR) milk consumptions were 532 mL
(262, 712 mL) in children and 266 mL (139, 563 mL) in the
adults. Daily bread consumptions were 117 g (80, 164 g) in
children and 101 g (63, 157 g) in adults. Because children con-
sumed more milk and bread than did adults, fortified products
provided median (IQR) vitamin D intakes of 8.0 mg/d (5.4, 10.0
mg/d) in children and 5.8 mg/d (3.5, 8.5 mg/d) in adults in the
fortification group, with an average of 6.8 mg/d (4.2, 9.5 mg/d).
Total median (IQR) vitamin D intakes (habitual diet plus fortified
products) were 9.2 mg/d (7.0, 12.3 mg/d) in the fortification group
and 2.2 mg/d (1.5, 3.0 mg/d) in the control group (with the con-
tribution from dietary supplements not included).
In the fortification group, 78% of children and 56% of adults
(average for children and adults: 66%) reached the vitamin D–
intake goal of 7.5 mg/d. By comparison, only 2% in the control
group had a vitamin D intake $7.5 mg/d. None of the partici-
pants exceeded the tolerable upper intake level.
Approximately 90% of participant total intake of milk and
bread was the study milk and bread (Table 1). Primary reasons for
participants drinking or eating other foods than study products
were children having school milk or eating in the day care center
and adults eating in the canteen at work.
Biochemical measures
The overall geometric mean (IQR) serum 25(OH)D concen-
tration changed from 73.1 nmol/L (61.9, 88.5 nmol/L ) to 67.6
nmol/L (56.2, 79.4 nmol/L) (difference: 2D5.5 nmol/L) for all
participants in the fortification group and from 71.1 nmol/L
(61.2, 85.9 nmol/L) to 41.7 nmol/L (29.5, 58.9 nmol/L) (2D29.4
nmol/L) in the control group. The final serum 25(OH)D concen-
tration was higher in the fortification group than in the control
group in both children and adults (both P, 0.001) (Table 2). The
combined analysis of children and adults with the primary linear
mixed model, which was adjusted for baseline 25(OH)D, sex, and
age, showed a treatment effect on the serum 25(OH)D concen-
tration (P , 0.001) so that the final 25(OH)D was estimated to be
59% higher in the fortification group than in the control group.
Additional adjustment of the model for BMI, multivitamin usage,
and sun vacation did not change the magnitude of the effect of
treatment (Table 3). No interaction effects were observed between
group and baseline serum 25(OH)D (P = 0.080), group and age
(P = 0.082), or group and sex (P = 0.317).
In the adult fortification group, 25(OH)D decreased from
months 0 to 3 (P, 0.001) and increased from months 3 to 6 (P =
0.014); nevertheless, the final concentration was lower than the
baseline concentration (P , 0.001). In the adult control group,
25(OH)D decreased from months 0 to 3 (P , 0.001) and con-
tinued decreasing from months 3 to 6 (P = 0.001). There was
a linear trend for the serum 25(OH)D concentration in adults in
both treatment groups (both P-trend , 0.001). In children,
25(OH)D decreased from months 0 to 6 in both the fortifi-
cation and control groups (both P , 0.001) (Table 2).
At baseline, ,1% of participants had a 25(OH)D concen-
tration ,30 nmol/L, and 8–9% of participants had a 25(OH)D
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concentration ,50 nmol/L with no differences between treat-
ment groups in their prevalence (P = 0.158 for ,30 nmol/L and
P = 0.814 for ,50 nmol/L). By the end of the study, ,1% of
subjects in the fortification group compared with 25% of sub-
jects in the control group had 25(OH)D concentrations ,30
nmol/L (P , 0.001), and 16% of subjects in the fortification
group compared with 65% of subjects in the control group had
25(OH)D concentrations ,50 nmol/L (P , 0.001) (Figure 2).
PTH and total calcium did not change during the study in the
fortification group (PTH: P = 0.099 for children and P = 0.156
for adults; calcium: P = 0.799 for children and P = 0.321 for
adults). By contrast, PTH increased and total calcium decreased
in the control group (PTH: P , 0.001 for both children and
adults; calcium: P = 0.041 for children and P = 0.001 for adults)
(Table 2).
The final PTH concentration was lower in the fortification
group than in the control group in both children and adults,
whereas there was no difference in final total calcium concen-
trations between treatment groups (Table 2). The combined
analysis of children and adults in linear mixed models adjusted
for baseline values of the endpoint, sex, and age showed a treatment
effect on PTH (P , 0.001) so that the final PTH was estimated to
be 9% lower in the fortification group than in the control group.
There was no treatment effect on total calcium (P = 0.237).
DISCUSSION
The fortification strategy in the current study resulted in
a higher serum 25(OH)D concentration in the fortification group
(67.6 nmol/L) than in the control group (41.7 nmol/L) at the end
of the winter season, despite the fact that 25(OH)D decreased in
both treatment groups during the study (2D5.5 nmol/L in the
fortification group and 2D29.4 nmol/L in the control group).
The planned fortification strategy was to increase the vitamin
D intake to the amount of 7.5 mg/d recommended in the NNRs
(34). This strategy succeeded in 78% of children and 56% of
the adults in the fortification group. As a result of the in-
creased intake, 84% of subjects in the fortification group had
TABLE 1
Characteristics and intakes in children and adults by treatment group
Children aged 4–17 y Adults aged 18–60 y
Fortification group
(n = 154)
Control group
(n = 167)
Fortification group
(n = 201)
Control group
(n = 204)
Sex [n (%)]
F 79 (51.3) 89 (53.3) 100 (49.8) 104 (51.0)
M 75 (48.7) 78 (46.7) 101 (50.2) 100 (49.0)
Age [n (%)]
4–10 y 80 (51.9) 83 (49.7) — —
11–17 y 74 (48.1) 84 (50.3) — —
18–40 y — — 106 (52.7) 86 (42.2)
41–60 y — — 95 (47.3) 118 (57.8)
BMI [n (%)]1
Normal weight 144 (93.5) 154 (92.2) 114 (56.7) 108 (52.9)
Overweight 9 (5.8) 13 (7.8) 66 (32.8) 67 (32.8)
Obese 1 (0.6) 0 (0.0) 21 (10.4) 29 (14.2)
Food consumption2
Milk (mL/d) 583 (357, 762)3 516 (212, 703) 289 (139, 550) 254 (139, 582)
Compliance (%)4 84 89 91 96
Bread (g/d) 124 (89, 240) 106 (72, 157) 92 (58, 151) 107 (67, 170)
Compliance (%)4 93 94 91 96
Vitamin D intakes (mg/d)2
Habitual diet 2.3 (1.7, 3.3) 2.2 (1.5, 2.9) 2.4 (1.6, 3.4) 2.2 (1.4, 3.1)
Fortified milk 2.3 (1.4, 3.1) 0 1.2 (0.6, 2.2) 0
Fortified bread 5.6 (3.5, 7.5) 0 4.2 (2.3, 6.6) 0
Total 10.2 (7.8, 13.1) 2.2 (1.5, 2.9) 8.1 (6.1, 11.5) 2.2 (1.4, 3.1)
$7.5 mg/d [n (%)] 114 (78.1) 1 (0.6) 103 (55.7) 7 (3.6)
Calcium intake (mg/d)2 979 (628, 1261) 921 (554, 1136) 695 (454, 979) 680 (437, 1035)
Supplement users [n (%)]5
Multivitamins 58 (39.2) 64 (39.3) 47 (25.1) 45 (23.1)
Vitamin D 3 (2.0) 5 (3.1) 3 (1.6) 11 (5.6)
Sun vacation [n (%)]5 43 (29.1) 32 (19.6) 57 (30.5) 38 (19.5)
1BMI categorization based on standards for children (40) and the WHO International standard for adults (41).
2 Intakes during the study. Sample sizes: n = 146 in the children fortification group and n = 162 in the control group and n = 185 in the adult fortification
group and n = 195 in the control group.
3Median; IQR in parentheses (all such values).
4 Percentage of total milk and bread consumptions that come from study products. Sample sizes: for milk compliance, n = 130 in the children fortification
group and n = 156 in the control group and n = 166 in the adult fortification group and n = 183 in the control group; for bread compliance: n = 140 in the
children fortification group and n = 156 in the control group and n = 179 in the adult fortification group and n = 191 in the control group.
5 Supplement usage and vacation in places where dermal vitamin D production was expected during the study. Sample sizes: n = 148 in the children
fortification group and n = 163 in the control group and n = 187 in the adult fortification group and n = 195 in the control group.
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a serum 25(OH)D concentration .50 nmol/L by the end of the
study.
The recently updated American Recommended Dietary Allow-
ance for vitamin D was set at 15 mg/d by the Institute of Medicine
(11). This value was estimated to ensure a target serum 25(OH)D
concentration of 50 nmol/L under conditions of minimal ex-
posure to the sun, such as under the circumstances in the current
study. The target value of 50 nmol/L was considered to cover
the requirement of the majority of the population in relation
to the optimal calcium absorption and related bone health.
TABLE 2
Biochemical measures in children and adults by treatment group at months 0, 3, and 61
Children aged 4–17 y Adults aged 18–60 y
Fortification group
(n = 154)
Control group
(n = 167) P
Fortification group
(n = 201)
Control group
(n = 204) P
25(OH)D (nmol/L)
Month 0 72.8 (64.0, 88.9) 72.8 (61.8, 83.9) 0.524 73.3 (61.9, 88.3) 70.0 (60.0, 86.7) 0.286
Month 32 — — — 63.1 (52.5, 77.6)** 44.7 (32.4, 63.1)** ,0.001
Month 6 67.6 (56.2, 79.4)** 42.7 (30.9, 58.9)** ,0.001 66.1 (56.2, 79.4)**,y 40.7 (28.8, 60.3)**,yy ,0.001
P-trend — — ,0.001 ,0.001
PTH (ng/L)
Month 0 35.0 (28.8, 41.5) 35.3 (27.6, 43.3) 0.969 35.5 (27.8, 44.2) 34.2 (26.9, 41.4) 0.268
Month 6 36.3 (27.5, 47.9) 41.7 (32.4, 52.5)** 0.028 36.3 (29.5, 45.7) 38.9 (30.9, 46.8)** 0.049
Total calcium (mmol/L)
Month 0 2.45 (2.40, 2.49) 2.47 (2.42, 2.51) 0.035 2.43 (2.37, 2.47) 2.43 (2.37, 2.49) 0.268
Month 6 2.45 (2.40, 2.50) 2.45 (2.40, 2.50)* 0.428 2.42 (2.37, 2.46) 2.41 (2.36, 2.47)** 0.423
1All values are geometric means; IQRs in parentheses. P values are for the comparison of treatment groups in biochemical measures at each time point
with linear mixed models with family as a random factor, group as a categorical variable, and the logarithm of the biochemical measure as the dependent
variable. Significant change within treatment groups analyzed in mixed models with family as a random factor and the difference between the logarithm of the
biochemical measure at time points of interest as the dependent variable: from month 0, *P , 0.05, **P # 0.001; from month 3, yP , 0.05, yyP # 0.001.
P-linear trend values in 25(OH)D are given for adults. PTH, parathyroid hormone; 25(OH)D, 25-hydroxyvitamin D.
2 Sample sizes: n = 186 in the adult fortification group and n = 195 in the control group.
TABLE 3
Effects of different variables on serum 25(OH)D concentrations at month 61
Variable
Model 1 (n = 726) Model 2 (n = 693)
Interpreted estimate (95% CI)2 P Interpreted estimate (95% CI)2 P
Treatment ,0.001 ,0.001
Fortification group 1.59 (1.49, 1.69) 1.58 (1.49, 1.67)
Control group 1 1
Baseline 25(OH)D 5.73 (4.84, 6.77)3 ,0.001 5.43 (4.60, 6.40)3 ,0.001
Sex 0.045 0.033
F 1.04 (1.00, 1.07) 1.04 (1.00, 1.08)
M 1 1
Age ,0.001 0.011
41–60 y 0.93 (0.88, 0.99) 0.013 0.97 (0.92, 1.03) 0.367
18–40 y 0.91 (0.87, 0.96) 0.001 0.95 (0.90, 1.00) 0.057
11–17 y 0.88 (0.83, 0.94) ,0.001 0.91 (0.86, 0.97) 0.003
4–10 y 1 1
BMI 0.782
Normal weight — 0.97 (0.90, 1.05) 0.484
Overweight — 0.98 (0.90, 1.06) 0.579
Obese — 1
Sun vacation ,0.001
Yes — 1.16 (1.10, 1.23)
No — 1
Multivitamin use ,0.001
Yes — 1.18 (1.12, 1.24)
No — 1
1Analyzed in linear mixed models with family as a random variable, variables as categorical variables, and the logarithm of the
serum 25(OH)D concentration as the dependent variable. 25(OH)D, 25-hydroxyvitamin D.
2Regression coefficients have been transformed exponentially (10b) so that values represent ratio estimates and corresponding
confidence limits.
3By a 10-fold increase in baseline 25(OH)D.
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A meta-regression analysis with supplemental vitamin D esti-
mated that 9–12 mg/d would be required for the general pop-
ulation to maintain 25(OH)D concentrations .50 nmol/L (44).
Our results suggested that w9 mg vitamin D/d would be suffi-
cient to ensure 25(OH)D concentrations .50 nmol/L in the
majority of 4–60-y-olds under conditions with usual habits during
a winter in Denmark including multivitamin supplement use and
sun vacation.
In the current study, the fortified milk and bread provided
a median vitamin D intakew7 mg/d. The difference between the
treatment groups in their absolute changes in the geometric
mean 25(OH)D concentration was w24 nmol/L. This amount
corresponded to a 3.4-nmol/L difference for each microgram of
vitamin D ingested from fortified foods. A recent meta-analysis
of the efficacy of vitamin D food fortification in adults showed
an average treatment effect of 1.2 nmol $ L21 $ mg21 (15). This
value is considerably lower than our result. It is to be noted that
a higher percentage of our participants compared with those in
the meta-analysis studies reported multivitamin supplement use
and sun vacation during the study. Furthermore, our study had
a relatively high mean baseline 25(OH)D and a relatively low
fortification amount, and the beneficial effect was expressed as
a reduction in the seasonal decline in 25(OH)D compared with
in the control group. Our observations were similar to those
of 2 other RCTs in 17–54-y-old men and women with base-
line 25(OH)D and fortification amounts comparable to those in
our study (18, 21). These studies showed treatment effects of
w2 nmol $ L21 $ mg21. Most studies had a lower initial starting
point than that of our study and observed an increase in 25(OH)D
after supplementation with vitamin D–fortified foods (16, 17, 19,
20, 22, 23, 25, 26, 28–31). An important conclusion from the
meta-analysis (15) and a systematic review by the NIH (45) was
the large heterogeneity between fortification studies. The studies
varied in design, study population, baseline 25(OH)D, food-
vehicle used, and fortification amounts. Therefore, the treatment
effects could not be directly compared and should be interpreted
with caution.
To our knowledge, a novelty in the design of the current study
was the combined use of 2 food vehicles consumed during the day
according to the participantsusual habits. This design was dif-
ferent from that in other randomized studies that used the effects
of single vitamin D–fortified foods consumed in a predefined
serving or amount. It has been shown that the efficiency of vi-
tamin D in fortified foods to improve serum 25(OH)D concen-
trations is equal to that of dietary supplements (22, 28, 29, 31),
and daily dosing with supplements was shown to be more effi-
cient than seasonal dosing in maintaining 25(OH)D (22). There-
fore, we consider that the larger treatment effect observed in the
current study compared with in other fortification studies sug-
gested that the response to vitamin D fortification in circulating
25(OH)D also depends on the daily frequency of ingestion.
One of the strengths of this study was the family and real-life
based design, which we believe was one of the main reasons for
the low dropout rate and high compliance. Informal feedback
from participants indicated that they made their participation
a joint family project, which they could discuss at dinner times,
and they encouraged and reminded one another to consume the
study products provided. It is important to consider this com-
pliance aspect in the design of future studies. The family-based
design also ensured a broad spread of age and sex in both children
and adults. Another strength was the use of a specific analytic
method to measure serum 25(OH)D concentrations.
An important finding was that the analyses of bread did not
fully recover all of the added vitamin D. We suspect that some of
the vitamin D was lost during baking. This loss was unexpected
because, in a previous fortification study, the added vitamin D
was recovered in both dough and baked wheat and rye breads
(31). This issue should be further investigated.
A minor drawback of the study was that the study population
may not have been fully representative of the general population
in Denmark. It is possible that the response to the fortification
would have been different in other population groups such as
elderly or dark-skinned groups. This possibility should be in-
vestigated in the future. However, if implementation of the for-
tification strategy was mandatory, the use of fortified products
would not depend on the consumers deliberate choice, which
could be influenced by factors such as age, sex, education, social
status, and ethnic affiliation.
This study showed that it is feasible to conduct RCTs in real-life
settings without compromising the treatment effect. Furthermore,
we showed the use of model data from usual food-consumption
intakes to establish an effective fortification strategy targeted at the
intended population. The combination of fortified milk and bread
proved suitable for 4–60-y-old Danes, partly because Danish
children and, to some extent, adults drink more milk than do
other population groups. Milk is not widely consumed in all
populations, whereas bread is a primary food in many countries.
Therefore, this study suggested that including bread in the current
selection of vitamin D–fortified foods could be an effective way to
attenuate seasonal fluctuations in vitamin D status.
In conclusion, vitamin D fortification of milk and bread, to an
amount that increased the intake to recommended amount, re-
duced the decrease in serum 25(OH)D concentrations during
winter and ensured 25(OH)D concentrations .50 nmol/L in
children and adults in Denmark.
We are grateful to the families for their active and enthusiastic participa-
tion. We thank the students from Metropolitan University College and the
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and we thank the staff at Copenhagen’s General Practitioners Laboratory
FIGURE 2. Prevalence of participants with serum 25-hydroxyvitamin D
concentrations ,30 and ,50 nmol/L at months 0 and 6 by treatment group.
*Significant difference between treatment groups as analyzed by using
binary logistic regression with a generalized estimating equation, P ,
0.001. Cutoffs defined the value below which adverse effects on bone
health may be expected and the value that would meet the requirement for
optimal bone health of the majority of the population according to the use in
the American dietary reference values for vitamin D (11).
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Abstract 34 
The importance of vitamin D in bone health is recognized and low concentrations have been 35 
associated with increased risk of disease. The impact of the family relation on vitamin D status has 36 
not been presented previously. The present cross-sectional study assessed serum 25-hydroxyvitamin 37 
D (25(OH)D) concentration and its determinants in children and adults among families in late 38 
summer in Denmark (56°N). Data from 755 apparently healthy children (4-17 years) and adults (18-39 
60 years) recruited as families (n 200) in the VitmaD study were analysed. Blood samples were 40 
collected in September-October, and serum 25(OH)D was measured by LC-MS/MS. Information on 41 
potential determinants was obtained by questionnaires. Geometric mean (interquartile range) serum 42 
25(OH)D concentration was 72·1 (61·5-86·7) nmol/l (range 9-162 nmol/l) with 9 % having 43 
25(OH)D <50 nmol/L. The intra-family correlation was 0.27 in all subjects, 0.24 in adults and 0.42 44 
in children. Serum 25(OH)D was negatively associated with BMI (P<0·001) and positively 45 
associated with dietary vitamin D (P=0·008), multivitamin use (P=0·019), solarium use (P=0·006), 46 
outdoor stay (P=0·001), sun preference (P=0·002) and sun vacation (P<0·001) but not with lifestyle 47 
factors in the adults when these were assessed together with the other determinants. In conclusion, 48 
the majority of children and adults among families had serum 25(OH)D concentrations >50 nmol/L 49 
in late summer in Denmark. Both dietary and sun related factors were determinants of vitamin D 50 
status, and the familial component was stronger for the children than for the adults. 51 
52 
 4 
 
Introduction 53 
The importance of vitamin D in bone health is recognized with rickets in children and osteomalacia 54 
and osteoporosis in adults being the traditional clinical conditions linked with vitamin D deficiency 55 
(1, 2)
. Furthermore, the expression of vitamin D receptors in different tissues 
(3)
 suggests additional 56 
biological functions of the vitamin. Low vitamin D status has been associated with a range of health 57 
outcomes 
(4, 5)
 including an increased risk of cardiometabolic disorders 
(6)
, some cancers 
(7)
, 58 
autoimmune diseases 
(8)
 and mortality 
(9)
. However, it is still unclear if these associations are causal. 59 
Studies have found vitamin D status to be associated with socio-demographic and lifestyle related 60 
factors 
(10, 11)
, thus, it may be that vitamin D status serves as an indicator of general health and/or 61 
lifestyle. 62 
The accepted biomarker of vitamin D status is 25-hydroxyvitamin D (25(OH)D) concentration in 63 
the blood 
(12)
. In Denmark the following values are used to define deficient, insufficient and 64 
sufficient serum 25(OH)D concentration: <25, 25-50, >50 nmol/l 
(13)
. The US Dietary Committee 65 
has defined 30 nmol/l as the limit beyond which adverse effects on bone might occur 
(14)
. A serum 66 
25(OH)D concentration of 40 and 50 nmol/L was used for the Estimated Average Requirement 67 
(EAR) and the Recommended Daily Allowance (RDA), which are assumed to meet the requirement 68 
in the average and the majority of the population for bone health. A threshold of >125 nmol/l was 69 
considered at-risk for harm by the US Dietary Committee. 70 
The use of cut-off values and the comparison of vitamin D status between studies is complicated by 71 
variations in measurements between methods as well as among laboratories using the same 72 
25(OH)D assay 
(15-17)
. In 2010 the National Institute of Standards and Technology (NIST) 73 
introduced a standard reference material for measurements of vitamin D in human serum 
(18)
 which 74 
is expected to improve the analytical performance of 25(OH)D measurements and to facilitate 75 
harmonization across 25(OH)D assays 
(15)
. 76 
Thus, there is a need for comparative data on vitamin D status yield by standardised and calibrated 77 
methods to better compare vitamin D status between population groups and evaluate the current 78 
situation of vitamin D deficiency. Vitamin D status has been measured in different population 79 
groups in Denmark 
(10, 19-23)
. None of the previous studies assessed a broad span in age and gender 80 
in both children and adults. Especially there is a lack of information on vitamin D status in young 81 
boys. One of the studies presented vitamin D status in men, women and girls from Danish 82 
 5 
 
immigrant families 
(23)
. However, to our knowledge, no previous studies have quantified the impact 83 
of the family relation for vitamin D status. This knowledge on vitamin D status within families will 84 
be helpful when considering strategies to improve vitamin D status.  85 
The objective of the present study was to assess serum 25(OH)D concentration and its determinants 86 
in children and adults among families in late summer in Denmark.87 
 6 
 
Subjects and methods 88 
Study population 89 
The present cross-sectional study used baseline data from the VitmaD study 
(24)
 conducted in 90 
Denmark (56°N). Children and adults were recruited as families randomly drawn from the Danish 91 
Civil Registration System. Inclusion criteria were age between 4 and 60 years and a permanent 92 
address in Gladsaxe municipality. Exclusion criteria were pregnancy and disease or use of 93 
medication influencing vitamin D metabolism (including dietary supplements with vitamin D levels 94 
>10 µg/d for children and >5 µg/d for adults, which corresponds to the typical levels in 95 
multivitamin supplements in Denmark). Of the 782 recruited children and adults. 755 (representing 96 
200 families) had serum 25(OH)D concentration measured and complete questionnaire data at 97 
baseline. The present analyses were conducted with these subjects. Written informed consent was 98 
obtained from all adult subjects and from the guardians of the children. The study was conducted 99 
according to the guidelines in the Declaration of Helsinki and the protocol was approved by the 100 
Research Ethics Committee of the Capital Region of Denmark (record no. H-4-2010-020) and 101 
registered in ClinicalTrials.gov (NCT01184716). 102 
Methods 103 
The subjects were examined and blood samples were collected in September-October 2010 in an 104 
authorized laboratory (Copenhagen´s General Practitioners Laboratory, Søborg, Denmark). Weight 105 
was measured to the nearest 0·1 kg in normal clothes without shoes (1 kg was withdrawn from the 106 
measured weight) with a body composition analyzer (Tanita BC-418, Tanita Europe B. V., 107 
Hoofddorp, The Netherlands). Height was measured to the nearest centimeter without shoes with an 108 
ultrasonic height measure (Soehnle 5001, Soehnle Professional GmbH & Co, Backnang, Germany). 109 
BMI was calculated based on the measured weight and height, and subjects were categorized into 110 
normal weight, overweight and obese classes according to standards for children 
(25)
 and the WHO 111 
International standard for adults 
(26)
. Non-fasting venous blood samples were drawn from the 112 
subjects, and serum and plasma were collected and stored at -80 ˚C until analysis. 113 
Serum 25(OH)D concentration was measured at the Clinical Biochemical Department, Holbæk 114 
Hospital, Denmark by isotope dilution liquid chromatography tandem mass spectrometry (LC-115 
MS/MS) using the principles described elsewhere 
(27)
. The method was calibrated against the NIST 116 
standard for analysis of vitamin D in human serum (SRM 972) 
(16)
, and the interassay CVs for our 117 
method were 2.2 % and 2.8 % at 30 and 180 nmol/L, respectively, for 25(OH)D3 and 7.6 % and 4.6 118 
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% at 43 and 150 nmol/L, respectively, for 25(OH)D2. The analytical quality of our method was 119 
assured by participation in the Vitamin D External Quality Assessment Scheme (DEQAS). In this 120 
validation scheme, the mean bias for our method compared with the mean of the DEQAS LC-MS 121 
group during the period of the present analyses was -3·2 %. Plasma parathyroid hormone (PTH) 122 
concentration was measured by using an immunology analyser (Cobas e601, Roche Diagnostics, 123 
Mannheim, Germany), following standard procedures from the manufacturer (CV = 3·4 %). 124 
Information on background, health, sun exposure and lifestyle, including use of multivitamin and 125 
vitamin D supplements of the subjects, was obtained in detailed self-administered web-based 126 
questionnaires. Dietary vitamin D intakes were registered in a semi-quantitative food frequency 127 
questionnaire (FFQ) adapted from a FFQ used in the EU project OPTIFORD 
(23)
. The vitamin D 128 
intakes were calculated based on the reported consumption frequencies and the vitamin D 129 
concentrations in the food items given in the Danish Food Composition Databank 
(28)
.  130 
Statistics 131 
Data were analysed with the SPSS statistical software (version 20.0, IBM SPSS Inc., Armonk, NY) 132 
and statistical significance was evaluated at a level of P<0·05 (two-sided). Linear mixed models 133 
with family as a random variable were applied in all analyses to account for the non-independency 134 
of the subjects. Before analysis serum 25(OH)D and PTH concentrations were logarithmically 135 
transformed to meet the model requirements. Trend analyses were performed to test for linear 136 
relations between PTH concentrations and 25(OH)D groups. Univariate models were used to assess 137 
the association between serum 25(OH)D and each of the following sun related variables: outdoor 138 
transport to school/work (<15, 15-30, 31-60, >60 min/d), solarium use at least once a week (yes, 139 
no), sun preference (prefer sun, sometimes in sun, avoid sun), outdoor stay in light clothes (most of 140 
the time, often, sometimes, seldom/never), sunscreen use (always, most of the time, sometimes, 141 
seldom/never), and sun vacation the preceding summer June-September (yes, no). Sun related 142 
variables with P<0·05 significance in their univariate model were included in a multiple analysis 143 
(linear mixed model) together with the following categorical variables: age (4-10, 11-17, 18-40, 41-144 
60 years), gender (female, male), BMI (normal weight, overweight, obese), dietary vitamin D 145 
(quartiles: <1·7, 1·7-2·4, 2·5-3·3, >3·3 µg/d), and multivitamin use (yes, no). The interaction 146 
between age and gender was tested. This multiple analysis was performed in all subjects and in 147 
children and adults separately. The strength of the familial component was considered by 148 
calculating the intra-class correlation for each model: ρ = ω2/(ω2+ σ2) , where ρ is the intra-family 149 
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correlation, σ is the within family standard deviation, and ω the between family standard deviation. 150 
The lower the variation within classes the higher the intra-class correlation which in this case means 151 
that the closer the correlation is to 1, the more alike are the subjects within a family with respect to 152 
their vitamin D status. 153 
The relation between serum 25(OH)D and each of the following lifestyle related variables was 154 
explored in univariate models in adults only: smoking status (current, former, never), alcohol 155 
consumption (never, <1 time/month, 1-3 times/month, 1 time/week, 2-4 times/week, 5-6 156 
times/week, daily), leisure-time physical activity (mainly sedentary, light to moderate activity, 157 
regular sport and exercise, athletic training), self-rated physical shape (really good, good, fairly 158 
good, bad, really bad), self-rated health (excellent, really good, good, less good/bad), effort to eat 159 
healthily (very often, often, sometimes, seldom/never), education after state and/or upper secondary 160 
school (none or technical education, higher education <3 years, higher education 3-4 years, higher 161 
education >4 years). Lifestyle related variables with P<0·05 significance in their univariate model 162 
were included in the multiple model described above. 163 
164 
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Results 165 
Characteristics of the subjects are given in Table 1 and Table 2. The median (interquartile range) 166 
ages of the youngest children (4-10 y), the oldest children (11-17 y), the youngest adults (18-40 167 
years) and the oldest adults (41-60 years) were 7 (6-9), 13 (12-15), 37 (33-39) and 45 (43-48) years. 168 
The genders were evenly distributed in both children and adults, and the majority of the subjects 169 
were of normal weight (Table 1). The median dietary vitamin D intakes were similar across age 170 
groups (range 2·3-2·6 µg/d). In the multivitamin users (41 % of the children and 25 % of the adults) 171 
the total median (interquartile range) vitamin D intake was 6·7 (4·5, 10·2) µg/d. Approximately half 172 
of the adults had a medium-long to long higher education, and their lifestyles were generally 173 
healthy (Table 2). 174 
The individual serum 25(OH)D concentrations (sum of 25(OH)D2 and 25(OH)D3) ranged from 9·3 175 
to 161·9 nmol/l with an overall geometric mean (interquartile range) of 72·1 (61·5-86·7) nmol/l. 176 
Serum 25(OH)D2 was found in 11 % of the samples in the range 3-29 nmol/L. Serum 25(OH)D 177 
concentration in the different age and gender groups and the distribution across its ranges is seen in 178 
Table 3. The overall prevalence of serum 25(OH)D <30, <40 and <50 nmol/l was 1, 2 and 9 % with 179 
no children being <30 nmol/l. In the adults, geometric mean PTH concentration (95 % CI) for the 180 
25(OH)D groups of <25, 25-49, 50-75 and >75 nmol/l was 59·8 (43.2-82.8), 39·9 (35·8, 44·3), 36·2 181 
(34·3, 38·2) and 32·7 (31·1, 34·4) ng/l (P trend<0·001). The same trend was seen in children aged 182 
4-10 years (P trend=0·012), but not in children aged 11-17 years (P trend=0·067).  183 
No differences were found in serum 25(OH)D between age (P=0·190), gender (P=0·332) or age 184 
and gender groups (P=0·223) in the multiple analysis of all subjects (Table 4). When children were 185 
analysed separately serum 25(OH)D was associated with gender (P=0·034) so that 25(OH)D was 186 
estimated 5 % lower in the girls compared with the boys. In the univariate models outdoor transport 187 
to work/school (P=0·972) and sun screen use (P=0·154) were not associated to 25(OH)D and thus 188 
not included in the multiple models. In the multiple analysis of all subjects serum 25(OH)D was 189 
negatively associated with BMI (P<0·001) and positively associated with dietary vitamin D 190 
(P=0·008), multivitamin use (P=0·019), solarium use (P=0·006), outdoor stay in light clothes 191 
(P=0·001), sun preference (P=0·002) and sun vacation (P<0·001) (Table 4). When children and 192 
adults were analysed separately serum 25(OH)D was not associated to BMI and sun preference in 193 
the children. In the adults the associations remained the same as in the model with all subjects but 194 
the significances for dietary vitamin D, multivitamin use and sun vacation were weakened. 195 
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From these multivariate models the variations in serum 25(OH)D concentration were higher within 196 
than between families with an intra-family correlation of 0·27 in all subjects. The intra-family 197 
correlation was higher in the children than in the adults (Table 5). 198 
In the further exploration of the adults serum 25(OH)D concentration was associated to leisure-time 199 
physical activity (P<0·001), self-rated physical shape (P=0·001) and self-rated health (P=0·003) in 200 
their univariate models. When these variables were included in the multiple analysis together with 201 
the vitamin D source related variables none remained significant, although leisure-time physical 202 
activity was borderline significant (P=0·054). Serum 25(OH)D was not associated to smoking 203 
status (P=0·722), alcohol consumption (P=0.070, effort to eat healthily (P=0·193) or education 204 
(P=0·219).   205 
206 
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Discussion 207 
The overall geometric mean serum 25(OH)D concentration among the families in the present study 208 
was 72·1 nmol/l with no differences between age and gender groups in the analysis of all subjects. 209 
The prevalence of 25(OH)D concentrations <25, <50 and <75 nmol/l were 1, 8 and 54 % with no 210 
children being <25 nmol/l. A novelty in our study was the quantitatively assessment of the familial 211 
component by calculation of the intra-class correlation. The intra-family correlation for all subjects 212 
was 0·27, which indicates that a subjects´ vitamin D status was not strongly related to the family 213 
relation. However, to our knowledge, no previous studies have quantified the familial component 214 
for vitamin D status and thus we do not have a number for comparison of the family relation. The 215 
intra-family correlation was almost the double in the children (0·42) as in the adults (0·24), which 216 
indicated that the children within a family were more alike than the adults within a family with 217 
respect to their vitamin D status. This might be an indication of the influence of genetic factors on 218 
vitamin D status or more similar habits in children than in adults from the same family. It is likely 219 
that children within a family share activities and dietary/supplementation habits to a larger extent 220 
than adults within a family for example outdoor stay, sun protection, multivitamin use and lunch in 221 
school. 222 
The serum 25(OH)D concentrations found in the present study were higher and the prevalence of 223 
25(OH)D <50 nmol/l was lower than the values reported in previous studies among similar age and 224 
ethnicity groups in Denmark 
(10, 20-23)
, other European countries 
(11, 23, 29-33)
, USA 
(34, 35)
 and Canada 225 
(36)
. Most of these studies measured vitamin D status across different seasons or in the winter as 226 
opposed to the late summer measurement in the present study, however, the prevalence of 25(OH)D 227 
<50 nmol/l found in the present study was also lower than the rates found during summer. Most of 228 
our participants were of normal weight which could favourable impact the serum 25(OH)D 229 
concentration compared with for example the high rate of obesity in the USA 
(37)
. Nevertheless, the 230 
studies should be compared with caution as differences may also depend on the laboratory and 231 
method used for serum 25(OH)D measurement 
(17)
. In the present study we used the LC-MS/MS 232 
method that might be considered the golden standard 
(38, 39)
, and our method was standardized and 233 
calibrated against the International reference material by NIST 
(18)
. The chromatographic methods 234 
are more specific compared with the frequently used immunoassays that are limited in their ability 235 
to detect vitamin D2 
(38, 40)
. In DEQAS (The Vitamin D External Quality Assessment Scheme) the 236 
LC-MS method is positively biased for the All-Laboratory Trimmed Mean (ALTM) whereas the 237 
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immunoassays are mostly negatively biased 
(17)
. Several studies have also found the LC-MS method 238 
to yield higher results than some other 25(OH)D assays 
(15, 16, 39, 40, 41)
. In a study of the German 239 
population standardization to the LC-MS/MS method reduced the prevalence of vitamin D 240 
deficiency (<30 nmol/l) from approximately 48 % to 16 % 
(42)
. This might partly explain the higher 241 
serum 25(OH)D concentrations found in the present study compared with previous studies in 242 
similar population groups.  243 
Similarly to the common finding of an inverse relation between 25(OH)D and PTH concentration 244 
(43)
, we observed a negative trend between PTH and 25(OH)D group in adults and the children aged 245 
4-10 years. In our study relatively few subjects had a low serum 25(OH)D concentration (<25 246 
nmol/l), but the PTH concentration was markedly higher in this group than in the other 25(OH)D 247 
groups. Elevated PTH concentrations may result in increased bone resorption in adults whereas the 248 
meaning for bone health in children is unclear 
(44)
.  249 
For all subjects outdoor stay in light clothes and sun vacation were major determinants for serum 250 
25(OH)D concentration in late summer. In the adults sun preference, solarium use and BMI were 251 
also strong determinants. We expected vitamin D status to be related to sun exposure as cutaneous 252 
vitamin D synthesis is considered the major source of vitamin D during the summer 
(45)
. It is 253 
interesting though that several expressions of the sun exposure were related to serum 25(OH)D 254 
concentrations at the same time. Most suggestive may be that vitamin D status was associated with 255 
sun vacation (abroad) despite that the hours of sunshine the preceding summer (2010) in Denmark 256 
was only slightly below (3 %) the average hours of sunshine for the preceding ten years 
(46)
. To our 257 
knowledge, this association between vitamin D status and sun vacation during the summer season 258 
has not been shown previously. The dietary vitamin D intake was also associated with serum 259 
25(OH)D concentration in this study despite  the median intake (2·5 µg/d) being much lower than 260 
the new recommended intake (RI) by the Nordic Nutrition Recommendation. The RI was recently 261 
increased from 7·5 µg/d to 10 µg/d for 2-60 year olds 
(47)
. This makes room for an even greater 262 
improvement in vitamin D intake, and our finding suggests that dietary vitamin D is also important 263 
during summer even in a group of children and adults that frequently stay outside. 264 
Vitamin D status was not associated with age in this study. Some previous studies have shown an 265 
association between vitamin D status and age in both children 
(35)
 and adults 
(11)
, whereas others did 266 
not find an association between 25(OH)D and age 
(10, 31, 32)
. The observed higher vitamin D status in 267 
boys compared with girls has been reported previously among similar age groups 
(48)
. In our study 268 
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this gender difference was not attributable to differences in dietary vitamin D intakes or 269 
multivitamin use. An explanation might be the higher level of physical activity in the boys 270 
compared to the girls (56 % of the boys compared to 35 % of the girls reported to do sport and 271 
physical active play in their leisure-time, results not shown) assuming that these activities were 272 
primarily outdoors. Serum 25(OH)D concentration was strongly inversely related to BMI in the 273 
adults, whereas there was no association in the children. This might be due to the fact that no 274 
children were categorised as obese and only a few were overweight. Another study with healthy 275 
weight children with a broad age span did not find an association between 25(OH)D and BMI or fat 276 
mass either 
(35)
. The association between 25(OH)D concentration and obesity is a common finding 277 
(11, 34, 49)
 and one explanation could be sequestration of vitamin D in fat tissue 
(50)
. 278 
In the adults serum 25(OH)D concentration was not related to lifestyle when assessed together with 279 
the influence of vitamin D source related factors except for a borderline relation with leisure-time 280 
physical activity. It might be that physical activity acts like a surrogate marker for sun exposure 281 
assuming that the activities are mainly outdoors. Previous studies have found an association 282 
between 25(OH)D and various lifestyle factors 
(10, 11)
. One study used an overall lifestyle index and 283 
found that vitamin D concentrations were substantially higher in those with the healthiest lifestyle 284 
compared with the less healthy lifestyle and that this difference was substantially higher than the 285 
differences between the single components of the lifestyle index 
(11)
. This suggests that high vitamin 286 
D concentrations may serve as an indicator of a generally healthy lifestyle. 287 
The strength of the present study was the random and population-based inclusion of families which 288 
made it possible to compare vitamin D status across age and gender groups. This has not been done 289 
previously in studies of the Danish population. Another strength was the use of detailed information 290 
on vitamin D sources including several variables for sun exposure, dietary vitamin D intake and 291 
supplement use. A limitation of the present study was that it was conducted at a single site in 292 
Denmark. However, our study population was large and randomly selected with few exclusion 293 
criteria and we believe that the results are likely to be generalizable. 294 
We presented vitamin D status in a representative sample of Danish families measured by a 295 
standardised and calibrated method and thus the results are useful for future comparisons of vitamin 296 
D status between populations. In conclusion, the majority of children and adults among families had 297 
serum 25(OH)D concentrations >50 nmol/l in late summer in Denmark. Vitamin D status was 298 
associated with BMI, dietary vitamin D, multivitamin use, solarium use, outdoor stay in light 299 
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clothes, sun preference and sun vacation, but not with lifestyle factors in the adults when these were 300 
assessed together with the other determinants. The children within a family seemed to be more alike 301 
than the adults within a family with respect to vitamin D status. 302 
303 
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Tables 
Table 1. Characteristics of the study population (n 755) 
 All subjects  Children  Adults 
 n %  n %  n % 
Gender         
     Female 386 51  178 52  208 50 
     Male 369 49  162 48  207 50 
Age        
 
     4-10 y 179 24  179 53  - - 
     11-17 y 161 21  161 47  - - 
     18-40 y 198 26  - -  198 48 
     41-60 y 217 29  - -  217 52 
BMI         
     Obese 54 7  1 <1  53 13 
     Overweight 156 21  20 6  136 33 
     Normal weight 545 72  319 94  226 55 
Dietary vitamin D*         
     Q1: <1·7 µg/d 186 25  85 25  101 24 
     Q2: 1·7-2·4 µg/d 193 25  83 24  110 27 
     Q3: 2·5-3·3 µg/d 186 25  93 27  93 22 
     Q4: >3·3 µg/d 190 25  79 23  111 27 
Multivitamin use         
     Yes 244 32  140 41  104 25 
     No 511 68  200 59  311 75 
Outdoor transport to school/work         
     <15 min/d 369 50  162 48  207 51 
     15-30 min/d 236 32  132 39  104 26 
     31-60 min/d 95 13  36 11  59 15 
     >60 min/d 43 6  10 3  33 8 
Solarium use         
     Yes 12 2  2 <1  10 2 
     No 743 98  338 99  405 98 
Outdoor stay in light clothes         
     Most of the time 408 54  199 59  209 50 
     Often 273 36  116 34  157 38 
     Sometimes 62 8  18 5  44 11 
     Seldom/never 12 2  7 2  5 1 
Sun preference         
     Prefer sun 246 33  103 30  143 35 
     Sometimes in sun 467 62  222 65  245 59 
     Avoid sun 42 6  15 4  27 7 
Sun screen use         
     Always 68 9  47 14  21 5 
     Most of the time 274 36  169 50  105 25 
     Sometimes 224 30  80 24  144 35 
     Seldom/never 189 25  44 13  145 35 
Sun vacation         
     Yes 363 48  168 49  195 47 
     No 392 52  172 51  220 53 
* Quartiles for the whole study population. 
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Table 2. Lifestyle related characteristics of the adult study population (n 415) 
 n % 
Education   
     None/technical 115 28 
     <3 years higher education 59 14 
     3-4 years higher education 133 32 
     >4 years higher education 108 26 
Smoking status   
     Current 77 19 
     Former 106 26 
     Never 232 56 
Alcohol consumption   
     Never 19 5 
     <1 time per month 61 15 
     1-3 times per month 103 25 
     1 time per week 67 16 
     2-4 times per week 124 30 
     5-6 times per week 27 7 
     Daily 14 3 
Leisure-time physical activity   
     Mainly sedentary 44 11 
     Light to moderate activity 155 37 
     Regular sport and exercise 168 41 
     Athletic training 48 12 
Self-rated physical shape   
     Really good 29 7 
     Good 154 37 
     Fairly good 167 40 
     Bad 53 13 
     Really bad 12 3 
Self-rated health   
     Excellent 51 12 
     Really good 167 40 
     Good 170 41 
     Less good/bad 27 7 
Effort to eat healthily   
     Very often 125 30 
     Often 211 51 
     Sometimes 65 16 
     Seldom/never 14 3 
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Table 3. Serum 25(OH)D concentrations and prevalence by age and gender groups among families in late summer in Denmark (56 °N)
 
 Girls  Boys  Women  Men All children All adults All subjects 
 4-10 years 11-17 years  4-10 years 11-17 years  18-40 years 41-60 years  18-40 years 41-60 years    
n 94 84  85 77  102 106  96 111 340 415 755 
Serum 25(OH)D (nmol/l)*               
   Geometric mean 71·7 70·3  76·0 72·2  74·1 70·7  71·2 71·0 72·5 71·7 72·1 
   Interquartile range 64·1, 82·0 59·9, 82·0  65·1, 89·5 63·1, 84·6  60·7, 87·7 60·0, 88·5  61·0, 87·4 61·3, 87·2 62·7, 84·9 60·8, 88·0 61·5, 86·7 
Prevalence (%)               
   <25 nmol/l 0 0  0 0  0 1  2 1 0 1 1 
   25-50 nmol/l 5 8  5 8  7 15  6 9 7 9 8 
   51-74 nmol/l 55 55  46 48  45 35  40 42 51 41 45 
   75-125 nmol/l 39 35  49 44  44 47  51 48 42 48 45 
   >125 nmol/l 0 2  1 0  5 2  1 0 1 2 2 
* No overall differences in serum 25(OH)D concentration between age (P=0·190), gender (P=0·332) and the combined age and gender groups (P=0·223) as analysed in the linear mixed model with family as a 
random variable, the following categorical variables: gender, age, BMI, dietary vitamin D, multivitamin use, solarium use, outdoor stay in light clothes, sun preference and sun vacation and the logarithm of the 
serum 25(OH)D concentration as the dependent variable. 
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Table 4. Associations between potential determinants and serum 25(OH)D concentrations
* 
 All subjects (n 755)  Children (n 340)  Adults (n 415) 
Variables Ratio of means† 95 % CI P  Ratio of means† 95 % CI P  Ratio of means† 95 % CI P 
Gender   0·332    0·034    0·792 
     Female 0·98 0·95, 1·02   0·95 0·91, 1·00   1·01 0·96, 1·06  
     Male 1 1   1 1   1 1  
Age   0·190    0·823    0·937 
     4-10 y 0·99 0·94, 1·05 0·778  1·01 0·96, 1·06   - -  
     11-17 y 0·95 0·91, 1·01 0·082  1 1   - -  
     18-40 y 1·01 0·96, 1·07 0·653  - -   1·00 0·94, 1·06  
     41-60 y 1 1   - -   1 1  
BMI   <0·001    0·348    0·001 
     Obese 0·83 0·77, 0·90 <0·001  0·97 0·61, 1·54 0·908  0·84 0·77, 0·92 <0·001 
     Overweight 0·97 0·92, 1·02 0·173  0·93 0·85, 1·03 0·148  0·98 0·92, 1·04 0·519 
     Normal weight 1 1   1 1   1 1  
Dietary vitamin D‡   0·008    0·065    0·034 
     Q1: <1·7 µg/d 0·92 0·87, 0·97 0·002  0·94 0·88, 1·00 0·068  0·91 0·84, 0·98 0·015 
     Q2: 1·7-2·4 µg/d 0·97 0·92, 1·02 0·284  0·95 0·88, 1·01 0·104  1·00 0·93, 1·08 0·982 
     Q3: 2·5-3·3 µg/d 1.00 0·95, 1·05 0·927  1·01 0·95, 1·08 0·741  0·99 0·92, 1·08 0·899 
     Q4: >3·3 µg/d 1 1   1 1   1 1  
Multivitamin use   0·019    0·066    0·045 
     Yes 1·06 1·01, 1·10   1·05 1·00, 1·11   1·07 1·00, 1·14  
     No 1 1   1 1   1 1  
Solarium use   0·006    0·199    0·007 
     Yes 1·2 1·06, 1·43   0·82 0·61, 1·11   1·29 1·07, 1·55  
     No 1 1   1 1   1 1  
Outdoor stay in light clothes   0·001    0·013    <0·001 
     Most of the time 1·30 1·11, 1·51 0·001  1·20 1·01, 1·43 0·034  1·58 1·20, 2·08 0·001 
     Often 1·29 1·11, 1·50 0·001  1·25 1·05, 1·49 0·011  1·51 1·15, 2·00 0·003 
     Sometimes 1·16 0·99, 1·36 0·063  1·32 1·10, 1·59 0·004  1·29 0·97, 1·71 0·083 
     Never/seldom 1 1   1 1   1 1  
Sun preference   0·002    0·621    0·001 
     Prefer sun 1·14 1·04, 1·25 0·004  0·96 0·85, 1·09 0·570  1·24 1·09, 1·40 0·001 
     Sometimes in sun 1·07 0·98, 1·17 0·116  0·95 0·84, 1·07 0·393  1·14 1·01, 1·29 0·034 
     Avoid sun 1 1   1 1   1 1  
Sun vacation   <0·001    <0·001    0·021 
     Yes 1·09 1·04, 1·15   1·11 1·06, 1·17   1·07 1·01, 1·14  
     No 1 1   1 1   1 1  
* Analyzed in linear mixed models with family as a random variable, the following categorical variables: gender, age, BMI, dietary vitamin D, multivitamin use, solarium use, outdoor stay in light clothes, sun 
preference and sun vacation and the logarithm of the serum 25(OH)D concentration as the dependent variable. 
† The regression coefficients have been exponentially transformed (10β) so that the figures represent the estimated ratio of means and the corresponding confidence limits. 
‡ Quartiles for the whole study population.
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Table 5. Standard deviations for within (σ) and between (ω) family effects and the intra-family 
correlation (ρ)* 
Parameter All subjects (n 755) Children (n 340) Adults (n 415) 
ω 0·060 0·063 0·061 
σ 0·098 0·074 0·11 
ρ† 0·27 0·42 0·24 
*
 
Derived from linear mixed models with family as a random variable, the following categorical variables: gender, age, 
BMI, dietary vitamin D, multivitamin use, solarium use, outdoor stay in light clothes, sun preference and sun vacation 
and the logarithm of the serum 25(OH)D concentration as the dependent variable. 
† Calculated as ρ = ω2/(ω2+ σ2).   
 
  
Paper 3: 
Relationship between winter vitamin D intake and status in Denmark. 
Madsen KH, Mejborn H, Tetens I, Andersen EW, Mølgaard C, Rasmussen LB, Andersen R. 
Submitted to American Journal of Clinical Nutrition 
 
 
 
1Relationship between winter vitamin D intake and status in Denmark 
Katja H. Madsen, Heddie Mejborn, Inge Tetens, Elisabeth W. Andersen, Christian Mølgaard, 
Lone B. Rasmussen and Rikke Andersen  
Division of Nutrition, National Food Institute, Technical University of Denmark, DK-2860 
Søborg, Denmark (KHM, HM, IT, LBR, RA) 
Department of Applied Mathematics and Computer Science, Technical University of 
Denmark, DK-2800 Lyngby, Denmark (EWA) 
Department of Nutrition, Exercise and Sports, Faculty of Science, University of Copenhagen, 
DK-1958 Frederiksberg C, Denmark and Hans Christian Andersen Children’s Hospital 
Odense University Hospital, DK-5000 Odense C, Denmark (CM) 
Correspondence 
Katja H. Madsen, Division of Nutrition, National Food Institute, Technical University of 
Denmark, Mørkhøj Bygade 19, DK-2860 Søborg, Denmark, Tel: +45 35 88 75 84, Fax: +45 
35 88 71 19, E-mail: kjma@food.dtu.dk 
Names for PubMed indexing: 
Madsen, Mejborn, Tetens, Andersen, Mølgaard, Andersen, Rasmussen 
Short title 
Vitamin D intake-status relationship 
Keywords
2Serum 25(OH)D, dose-response, children, adults 
Abbreviations 
25(OH)D, 25-hydroxyvitamin D; DEQAS, Vitamin D External Quality Assessment Scheme; 
FFQ, Food Frequency Questionnaire; LC-MS, liquid chromatography mass spectrometry; 
IQR, interquartile range; NNR, Nordic Nutrition Recommendation; RDA, Recommended 
Daily Allowance; RI, Recommended Intake. 
Funding 
This research was supported by grants from the Danish Dairy Research Foundation, the 
Centre for Advanced Food Studies, and the European Regional Development Fund. They had 
no role in the design, analysis or writing of this article. 
Trial registration 
This trial was registered at clinicaltrials.gov as NCT01184716. 
3Abstract 
Background: How much vitamin D is needed to maintain an optimal vitamin D status year-1
round is unknown. Objective: The present study investigated the relationship between actual 2
vitamin D intake and status, taking into account effect modifiers and the estimated required 3
winter vitamin D intake in healthy Danish people aged 4-60 years. 4
Design: Blood samples (n = 692) were collected in September-October and March-April, and 5
serum 25-hydroxyvitamin D (25(OH)D) concentration was measured by LC-MS/MS. Dietary 6
intake was determined by a self-administered FFQ.7
Results: The median (IQR) total vitamin D intake was 6.2 (2.8-11.1) μg/d and the geometric 8
mean 25(OH)D was 52.2 (39.1-73.1) nmol/L. The vitamin D intake-status relationship was 9
best fitted using a log-transformation. The effect of vitamin D intake on serum 25(OH)D was 10
4% higher in men compared with women and 10% higher in the group with the lowest initial 11
25(OH)D (<61.5 nmol/L) compared with the group with the highest initial 25(OH)D (>86.9 12
nmol/L). An estimated intake of 5, 11, 23 and 39 μg/d was required for 50, 75, 90 and 95% of 13
the population to maintain a vitamin D status >50 nmol/L during winter. It was higher for the 14
group with the lowest initial 25(OH)D (11, 18, 34 and >34 μg/d) and lower for the group with 15
the highest initial 25(OH)D (<1, 3, 8 and 17 μg/d). 16
Conclusion: The vitamin D intake-status relationship in a population of Danish families was 17
non-linear and modified by gender and initial vitamin D status. 18
4Introduction 19
Vitamin D is provided by endogen synthesis in the skin after UVB exposure and by intake 20
through the diet and dietary supplements. Exposure to sunlight is considered the main source 21
of vitamin D in the general population (1). However, when sun exposure is restricted, for 22
example during winter at higher latitudes (2), vitamin D from intake becomes essential (3). 23
Moreover, limited sun exposure as a consequence of changes in life style, such as spending 24
more time indoors and increased awareness about skin cancer (4), means that vitamin D 25
intake may play a more important role than previously assumed (5).  26
It is unclear how much vitamin D is needed to maintain an optimal vitamin D status all year 27
round. Furthermore, while there is consensus about serum 25-hydroxyvitamin D (25(OH)D) 28
being the best marker for vitamin D status (6), there is less agreement on the concentration 29
defining the optimal status. The traditional approach was to determine sufficiency as the level 30
at which the short-latency diseases for vitamin D deficiency, rickets and osteomalacia, were 31
avoided. However, the prevention of the clinical symptoms of these diseases is not the same 32
as the optimal status, because less severe degrees of deficiency can produce longer-latency 33
diseases such as osteoporosis (7). Current research focuses on defining the optimal vitamin D 34
intake and status for health outcomes rather than the lack of explicit clinical disease (8). Fifty 35
nmol/L is the target used in the Nordic Nutrition Recommendation (NNR) for its 36
Recommended Intake (RI) of 10 μg/d (9) and by the US Dietary Committee for its 37
Recommended Daily Allowance (RDA) of 15 μg/d to define the optimal intake for bone 38
health (10). In the present study, we operated with the limits of 25 and 50 nmol/l that are 39
commonly used in Denmark to define deficiency and sufficiency (11). 40
5Most supplemental studies have found that vitamin D intake increases the concentration of 41
serum 25(OH)D, but various dose-response approaches have been used (12). Some have 42
looked at the change in serum 25(OH)D concentration, whereas others have looked at the 43
absolute 25(OH)D concentration as a function of the vitamin D intake. Earlier studies used 44
specified doses, often beyond the recommended range, and most were conducted with adults. 45
It is well-known that supplemental effects may depend on many factors, so dose-response 46
studies have been criticized for not paying attention to these factors, especially the initial 47
vitamin D status (13). 48
The aim of the present study was to investigate the relationship between total vitamin D 49
intake from natural foods, fortified foods and dietary supplements, and the vitamin D status in 50
children and adults in late winter in Denmark, taking into account the initial vitamin D status, 51
age, gender and BMI class. Furthermore, we estimated the vitamin D intake needed to 52
maintain 25(OH)D concentrations >25 and >50 nmol/L in specified proportions of the 53
population. 54
6Participants and methods 
Study population 55
The present study used data from the VitmaD intervention (14) conducted in Denmark 56
(56°N). Apparently healthy children and adults aged 4-60 years were recruited as families 57
randomly drawn from the Danish Civil Registration System. The families received either 58
vitamin D fortified or non-fortified milk and bread for six months during the winter 59
(September 2010–April 2011). They were requested to replace their usual consumption of 60
bread and milk with the study products and in all other aspects to live their lives as normal. 61
Participants were examined as previously described in detail (22) and categorized into BMI 62
classes based on standards for children (15) and the WHO standard for adults (16). Out of the 63
782 participants recruited, 692 had serum 25(OH)D concentrations measured both at baseline 64
and at the end of the study as well as complete questionnaire data. The present analyses were 65
conducted with these participants. Written informed consent for participation was obtained 66
from all adult participants and from the guardians of the children. The study protocol was 67
approved by the Research Ethics Committee of the Capital Region of Denmark (record no. H-68
4-2010-020) and registered in ClinicalTrials.gov (NCT01184716). 69
Serum 25(OH)D concentration 70
Non-fasting venous blood samples were drawn in an authorized laboratory (the Copenhagen 71
General Practitioners’ Laboratory, Søborg, Denmark). The serum was collected and stored at 72
-80 ˚C until analysis. All blood samples were analyzed as single determinations in a random 73
order at the Clinical Biochemical Department, Holbæk Hospital, Denmark. Serum 25(OH)D 74
concentrations were determined by isotope dilution liquid chromatography tandem mass 75
spectrometry (LC-MS/MS) using principles described elsewhere (17). The method was 76
7calibrated with the standard reference material vitamin D in human serum (SRM 972) (18). 77
The interassay CVs for our method were 2.2% and 2.8% at 30 and 180 nmol/L, respectively, 78
for 25(OH)D3 and 7.6% and 4.6% at 43 and 150 nmol/L, respectively, for 25(OH)D2. The 79
analytical quality of our method was assured by participation in the Vitamin D External 80
Quality Assessment Scheme (DEQAS). In this validation scheme, the mean bias for our 81
method compared with the mean of the DEQAS LC-MS group during the period of the 82
present analyses was -3.2%. 83
Vitamin D intake 84
Information on vitamin D intake was obtained from detailed self-administered web-based 85
questionnaires. Dietary vitamin D intake was registered in a semi-quantitative food frequency 86
questionnaire (FFQ) adapted from an FFQ used in the European Union project Towards a 87
strategy for Optimal Vitamin D Fortification (19). The vitamin D intake from natural foods 88
was calculated based on the reported consumption frequencies and the vitamin D 89
concentrations in the food items given in the Danish Food Composition Databank (20). The 90
vitamin D intake from the fortified foods was calculated based on the reported consumption 91
frequencies for milk and bread and the measured concentrations of vitamin D in these 92
fortified products (14). The contribution of vitamin D from dietary supplements was 93
calculated as the frequency of use multiplied by the self-reported content of vitamin D in the 94
supplement used. The total vitamin D intake used in the present analysis is the sum of vitamin 95
D from natural foods, fortified milk and bread, and dietary supplements.96
Statistics 97
The data were analyzed using the STATA statistical software (StataCorp. 2011, Stata 98
Statistical Software: Release 12, College Station, TX: StataCorp LP) and their statistical 99
significance was evaluated at a level of P<0.05 (two-sided). Mixed models with family as a 100 
8random factor were applied in all analyses to take account of the non-independency of the 101 
participants. Before analysis, serum 25(OH)D concentrations were logarithmically 102 
transformed to meet the model requirements. 103 
The dose-response relationship between the total vitamin D intake and the serum 25(OH)D 104 
concentration at the end of the winter was modeled as: linear, square, logarithm and restricted 105 
cubic spline with knots at 0.8, 4, 8 and 25. The fit of the various curves was compared using 106 
Akaike’s Information Criterion (AIC) with small values indicating the best fit. Using the best 107 
fitted model, gender, age group (4-10, 11-17, 18-40, 41-60 y), BMI class (normal, 108 
overweight, obese), and initial serum 25(OH)D concentrations in four equal-sized groups 109 
were included as explanatory variables in the initial model. In this joint model, interactions 110 
with total vitamin D intake were tested, one at a time, to see whether any of these factors 111 
modified the effect of total vitamin D intake on serum 25(OH)D concentration. The vitamin D 112 
intake needed to maintain serum 25(OH)D above 25 and 50 nmol/L in 50, 75, 90, 95 and 113 
97.5% of the population were determined by the lower prediction limits calculated using the 114 
method described by Jiang and Zhang (21).  115 
9Results 
Individual serum 25(OH)D concentrations at the end of the winter ranged from 8.2 to 192.9 116 
nmol/L with an overall geometric mean (IQR) of 52.2 (39.1, 73.1) nmol/L. The initial serum 117 
25(OH)D concentration was 72.0 (61.4, 86.8) nmol/L. Individual total vitamin D intake 118 
ranged from 0.2 to 39.1 μg/d with a median (IQR) of 6.2 (2.8, 11.1) μg/d. 119 
Table 1 shows the contributions from natural foods, fortified foods and dietary supplements 120 
to the total vitamin D intake. Approximately half of the participants received fortified 121 
products and 39% of the children and 26% of the adults (overall 32%) used dietary 122 
supplements with vitamin D. The majority used multivitamins. Total vitamin D intake 123 
decreased with the decreasing number of sources for vitamin D, and the serum 25(OH)D 124 
concentrations followed the same pattern. Thus, both vitamin D intake and status were highest 125 
in the participants receiving vitamin D from all three sources (Table 1). In the group receiving 126 
vitamin D from all three sources, 78.6% had a total vitamin D intake of ≥10 μg/d, whereas 127 
less than 1% reached this level in the group receiving vitamin D from natural foods only.  128 
The intake-response relationship between the total vitamin D intake and the serum 25(OH)D 129 
concentration was best fitted in a log-model yielding a non-linear association (Figure 1).130 
From this model, a doubling in the vitamin D intake was estimated to result in an 18% (95% 131 
CI: 15, 21%) increase in serum 25(OH)D (P < 0.0001). An intake of 10 μg/d predicted a 132 
serum 25(OH)D concentration (95% CI) of 60.2 (57.5, 63.0) nmol/L (Table 2).  133 
This effect of the total vitamin D intake on serum 25(OH)D concentration was not modified 134 
by age group (P = 0.132) or BMI class (P = 0.884), but was modified by gender (P = 0.014) 135 
and initial 25(OH)D group (P < 0.001). For each doubling of vitamin D intake, 25(OH)D in 136 
men increased by 4% more than in women, and vitamin D intake has a 10% higher effect on 137 
10 
participants in the lowest starting 25(OH)D group than on participants in the highest starting 138 
25(OH)D group (Table 3).139 
Based on the initial simple mixed model, total vitamin D intakes of 39, 23, 11 and 5 μg/d 140 
were required to maintain a winter vitamin D status above 50 nmol/L in 95, 90, 75 and 50% 141 
of the population (Figure 2). Similarly 95, 90, 75 and 50% would be above 25 nmol/L with 142 
daily intakes of 4, 3, 1 and <1 μg/d. Because the effect of vitamin D intake was dependent on 143 
the starting 25(OH)D level, lower vitamin D intakes were needed for the highest starting 144 
25(OH)D group to have the same effect on vitamin D status as the lowest starting 25(OH)D 145 
group (Table 4). Thus, for 90% of the population to maintain a vitamin D status above 50 146 
nmol/L during winter, 8 μg/d were required in the highest starting 25(OH)D group compared 147 
with an intake of 34 μg/d required in the lowest starting 25(OH)D group.  148 
11 
Discussion 
We found that the relationship between the total vitamin D intake and status was best fitted by 149 
a non-linear curve and that the relationship was modified by gender and initial vitamin D 150 
status but not by age and BMI. This non-linear relationship is similar to previous observations 151 
(12, 22-27), whereas others have reported response estimates based on linear analyses (6, 12, 152 
22, 28-35). These response curves have been found to deflect at an intake of 25 μg/d (27) or 153 
35 μg/d (22). In the relatively narrow vitamin D intake interval in the present study, the dose-154 
response curve deflected ~6 μg/d. 155 
Studies of vitamin D supplementation in various doses and durations have yielded rate 156 
constants from 0.4 to 5.0 nmol·L-1·μg-1 with a mean of 2.1 nmol·L-1·μg-1 (36). The value of 157 
2.0 nmol·L-1·μg-1 has been estimated to be a risk-averse approach to use when setting dietary 158 
recommendations (36). Studies using higher doses have found lower constants in the range 159 
0.66-1.15 (22, 26, 28, 37). Meta-regression analyses using linear modeling have found slopes 160 
of 0.4-0.8 nmol/L·μg-1 (6, 29). However, the figures can be calculated by different means; 161 
some have used the change in vitamin D status, while others have used the final vitamin D 162 
status as a function of vitamin D dose, as we did in the present study. Our study was different 163 
in that we used the actual total vitamin D intake instead of controlled doses. Systematic 164 
reviews have also concluded that studies have been heterogeneous in their design, population 165 
and 25(OH)D assay (12, 27, 31), which may well explain the observed differences between 166 
studies. 167 
In the present study, the response to vitamin D intake in serum 25(OH)D concentration was 168 
not modified by age, but the response in men was higher than in women. This has also been 169 
found in older people (≥64 y) (34), but most other studies have not found an effect of gender 170 
12 
(22, 26) or age (12, 22, 27, 38). While obese people have been found to respond less to 171 
vitamin D supplementation than thin people (39, 40), BMI class was not an effect modifier in 172 
the present study. Others have not found the response in 25(OH)D to vitamin D intake to be 173 
affected by BMI either (22, 25, 32, 37, 38). On the other hand, the BMI interval in our study 174 
was relatively narrow and most participants were normal weight, which might explain the 175 
lack of effect of BMI class on the response to vitamin D intake. The response in serum 176 
25(OH)D concentration to vitamin D intake was larger for the group with the lowest initial 177 
25(OH)D than for the group with the highest initial 25(OH)D, which is a common finding 178 
(22, 23, 26, 27, 31, 38, 41). It has been suggested that this is to be explained by the 179 
acceleration of the hydroxylation of 25(OH)D into inactive metabolites with increases in 180 
25(OH)D creating a threshold effect (41).  181 
The estimated vitamin D intake required to maintain a specific serum 25(OH)D concentration 182 
during winter varied depending on the 25(OH)D goal and the selected proportion of the 183 
population. For example 39 μg/d was needed to sustain a vitamin D status >50 nmol/L in 95% 184 
of the population. The intake required was reduced to 23 μg/d if the proportion was set to 185 
90% and again to 11 μg/d for 75% and 5 μg/d for 50%. The estimated intake to maintain 186 
25(OH)D in 95% of the population was higher for the 50 nmol/L goal and lower for the 25 187 
nmol/L goal compared with previous estimates in children, adults and the elderly (24, 32, 34). 188 
The intake required for the median of the three population groups to be >50 nmol/L was 10.4, 189 
10.2 and 7.1 μg/d, respectively, which are all higher than our estimate of 5 μg/d. Interestingly, 190 
the meta-analysis by Cashman et al. estimated that a vitamin D intake of only 9-12 μg/d was 191 
needed to sustain 97.5% of the population above 50 nmol/L during winter (12). These 192 
differences may be largely due to the different methods used for analysis of 25(OH)D (42-193 
44). 194 
13 
Similarly, the initial vitamin D status had a considerable influence on the vitamin D intake 195 
required to maintain a specified vitamin D status. For example, for 90% to be above 50 196 
nmol/L, the required intakes were 34, 22, 19 and 8 μg/d for the four initial vitamin D status 197 
groups, respectively, despite the fact that the range between the four groups was relatively 198 
small (<61.5 to >86.9 nmol/L) and that the lowest group was not critically low. Similarly, 199 
others have found that lower vitamin D intakes were needed in groups with higher initial 200 
25(OH)D than in groups with lower initial 25(OH)D (22, 32). Sun exposure may be a 201 
surrogate marker for summer vitamin D status or vice versa. Studies estimating required 202 
vitamin D intake based on sun exposure groups found less differences in the required intake 203 
between high (7.9-8.8 μg/d) and low sun exposure groups (11.4-12.3 μg/d) (24, 34) than we 204 
did between the corresponding high and low initial 25(OH)D groups (<1 and 11 μg/d for 205 
97.5% >25 nmol/L). This supports the view that initial vitamin D status and/or cutaneous 206 
synthesis during the summer probably offsets the dietary requirement for vitamin D during 207 
winter (24, 32). In Danish girls (11-13 y) and women (70-75 y) with a typical dietary vitamin 208 
D intake (2.3-3.3 μg/d), usual summer sun exposure and no supplement use, a summer 209 
vitamin D status of 100 nmol/L was estimated to be needed to maintain vitamin D status 210 
above 50 nmol/L during winter (45). Our study supports that an intake of ~3 μg/d is sufficient 211 
to maintain 75% of the population >50 nmol/L during winter if the summer vitamin D status 212 
is >86.9 nmol/L. Intake-sun modeling has shown that 28 μg/d was needed to maintain the 213 
average vitamin D status above 50 nmol/L with usual outdoor behaviors in British adults (1 h 214 
on week days and 1.5 h on weekend days) (3). This intake is five times as much as our 215 
estimated required intake and more than the double the intake estimated by Cashman et al. 216 
(24, 32, 34).217 
14 
What the relative contributions from oral intake and sunlight exposure should be to maintain 218 
an adequate vitamin D status is still not clear (3). Furthermore, it is not known how much 219 
impact the seasonal fluctuations in vitamin D status have on health (32). It might be that 220 
people who live in northern latitudes have adapted to these circumstances (1), so that some 221 
decline in serum 25(OH)D concentration during winter is acceptable and that a chronically 222 
low concentration is the condition more critical for long-term health. Nevertheless, vitamin D 223 
from the diet or dietary supplements is a requirement in most people during winter (24) and as 224 
the present and previous studies have demonstrated, the required vitamin D intake depends on 225 
several factors. One novelty in our study is that we estimated the required vitamin D intake 226 
based on the initial vitamin D status. The strengths of the present study are the broad span in 227 
age for both genders and the use of actual total vitamin D intake instead of predetermined 228 
doses to model the dose-response. However, this also poses an uncertainty factor in the 229 
estimated intake, because they are based on the subjects’ self-reported usual dietary intake. 230 
In conclusion, the dose-response between the total vitamin D intake from natural foods, 231 
fortified foods and dietary supplements and serum 25(OH)D concentrations in a sample of 232 
Danish children and adults was best modeled by a non-linear relation. This relationship was 233 
modified by gender and initial vitamin D status, but not by age and BMI.  234 
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Table 2. Predicted late winter serum 25(OH)D concentration (95% CI) for specified total 
vitamin D intake in the initial simple log mixed model with family as random factor (n = 692) 
Vitamin D intake
(μg/d) 
Predicted serum 25(OH)D 
(nmol/L) 
2 41.1 (38.9, 43.3) 
5 51.1 (49.0, 53.2) 
10 60.2 (57.5, 63.0) 
15 66.3 (62.8, 69.9) 
20 71.0 (66.7, 75.3) 
25 74.9 (69.9, 79.9) 
30 78.2 (72.6, 83.8) 
35 81.1 (75.0, 87.3) 
40 83.8 (77.1, 90.4) 
25 
Table 3. Estimated effect of total vitamin D intake for gender and for the four groups of 
initial vitamin D status (n = 688)
n Estimated fold increase in 
25(OH)D per doubling in total 
vitamin D intake (95% CI)*
p
Gender    
   Females 354 1.13 (1.10, 1.16) <0.0001 
   Males 334 1.17 (1.15, 1.20) <0.0001 
Initial serum 25(OH)D†    
   <61.5 nmol/L 173 1.20 (1.16, 1.24) <0.0001 
   61.5-73.4 nmol/L 171 1.18 (1.14, 1.22) <0.0001 
   73.4-86.9 nmol/L 172 1.13 (1.09, 1.17) <0.0001 
   >86.9 nmol/L 172 1.10 (1.06, 1.14) <0.0001 
*All estimates are adjusted for gender, age group, BMI class and initial vitamin D status in a log mixed model 
with random family effect. 
† Groups according to quartiles for the initial serum 25(OH)D concentration. 
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Table 4. Estimated vitamin D intake to maintain vitamin D status above 25 or 50 nmol/L in 
specified proportions of the population during winter for the four initial vitamin D status 
groups (n = 688)*
Vitamin D intake (μg/d) 97.5% limit 95% limit 90% limit 75% limit 50% limit
Aim >50 nmol/L      
Overall  39 23 11 5 
Initial <61.5 nmol/L - - 34 18 11 
Initial 61.5-73.4 nmol/L - 37 22 1 6 
Initial 73.4-86.9 nmol/L - 37 19 7 4 
Initial >86.9 nmol/L 39 17 8 3 <1 
      
Aim >25 nmol/L      
Overall 6 4 3 1 <1 
Initial <61.5 nmol/L 11 7 5 3 2 
Initial 61.5-73.4 nmol/L 7 4 3 2 <1 
Initial 73.4-86.9 nmol/L 4 2 <1 <1 <1 
Initial >86.9 nmol/L <1 <1 <1 <1 <1 
* Prediction limits are based on a simple log mixed model with random family effect. 
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Figure legends 
Figure 1. Four different models for the relationship between total vitamin D intake and serum 
25(OH)D concentrations in Danish people aged 4-60 years at the end of the winter. Models 
are simple mixed models with family as a random factor (n = 692) 
Figure 2. Prediction limits based on simple log2 mixed models with random family effect (n
= 692). Horizontal lines mark the points where serum 25(OH)D concentrations of 25 and 50 
nmol/L are reached for the specified prediction limits 
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